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1 
INTRODUCTION 
Bovine respiratory tract disease has become increasingly recognized 
and accepted as a complex which includes a variety of clinical syndromes. 
During the past 25 years substantial efforts have been made to control 
this disease complex. These efforts have resulted in the isolation, 
characterization and identification of a number of viral and bacterial 
agents believed to be involved in bovine respiratory tract disease. These 
efforts have also resulted in new prophylactic vaccines and preventive 
programs involving management practices. However, the magnitude and com­
plexity of the problem still exists almost unchanged. 
With the increased knowledge about the bovine respiratory tract dis­
ease complex it soon becomes evident that more exact knowledge about 
etiologic agents in epizootics is needed. The search for new viral agents 
involved in this complex disease resulted in the isolation of a bovine 
adenovirus type 3 from feedlot cattle with acute respiratory tract disr 
ease. 
The purpose of this study was to describe the isolation, characteri­
zation and identification of this virus. A serologic survey was conducted 
to help evaluate the importance and role of bovine adenovirus type 3 in 
outbreaks of bovine respiratory tract disease. Experimental infection of 
calves was conducted in order to study the pathogenicity of this agent. 
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LITERATURE REVIEW 
The name for the adenovirus family was derived from the fact that the 
first isolation of this new virus was from a culture of human adenoids 
(31). In 1953 Rowe and colleagues noticed spontaneous cytopathic changes 
after prolonged incubation of uninoculated as well as inoculated cultures 
of human adenoids (80). These changes were shown to be due to the emer­
gence of an unidentified viral agent from latent infections. At about the 
same time Hilleman and Werner isolated an agent with similar cytopathic 
activity in human tissue culture from respiratory tract secretions col­
lected during an epidemic of influenza-like disease in army recruits (41). 
Adenoviruses now comprise a rather well-defined group of viruses with 
wide distribution in nature (66,67). Members of this family of virus con­
tain a linear double-stranded deoxyribonucleic acid (DNA) core with 252 
capsomers in icosahedral symmetry. There are 240 hexon capsomers and 12 
penton capsomers, one at each of the apices of the icosahedral polygon. A 
fiber, the length of which depends upon the serotype, is attached to each 
penton capsomer. The virion has a diameter of between 65 and 90 nm, with 
an average of 70 nm. Since they lack an envelope adenoviruses are re­
sistant to lipid solvents. Heat (i.e., 56 C for 5 minutes) will inacti­
vate the virus while at 4 C unpurified virus can be stored for several 
months. The virus has maximum stability at pH 6.0 to 7.0 and is less 
stable to extremes of alkalinity than to extremes of acidity. Most mem­
bers of the family hemagglutinate red blood cells. Adenoviruses are 
generally highly host specific and this specificity provides the basis for 
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virus grouping. In susceptible cells they replicate and mature within the 
nucleus producing a characteristic cytopathic effect (CPE) with intra­
nuclear inclusions. Infected cells generally become rounded, highly re-
fractile, and granular. Thin cytoplasmic strands often interconnect 
neighboring cells. Epithelial cells are usually a better host system for 
adenovirus than are fibroblastic cells. 
The antigenic structure of the adenoviruses is complex. The differ­
entiation of type-, subgroup-, and group-specific cross reactivity is not 
always completely clear. On the basis of morphologic studies it has been 
determined that the hexon capsomer contains the group-specific complement-
fixing and immunodiffusion antigen shared by all adenoviruses except the 
avian and subgroup 2 bovine adenoviruses which share another common com­
plement-fixing antigen. A type-specific antigen is also located in small 
quantities on the hexon capsomer. The penton capsomer comprising the 
vertex capsomer, fiber and terminal knob consists partially of subgroup-
specific antigens but largely of type-specific antigen. The penton cap­
somer can be cleaved by trypsin treatment to yield the penton base and the 
fiber with terminal knob. The fiber with terminal knob contains a pre­
dominance of type-specific antigen. While this terminology for the anti­
gens enables association with the morphologic unit, it must be remembered 
that each morphologic unit is not antigenically homogeneous. Philipson 
and Pettersson recently reviewed the properties of adenovirus antigens 
(68) .  
At present there are 9, and possibly 10 bovine adenovirus serotypes 
(36,37,50,52,57,61,89)- The Western Hemisphere Committee on Animal 
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Virus Characterization officially recognizes 5 serotypes (89). The World 
Health Organization/Food and Agriculture Organization Board of Comparative 
Virology has given official acceptance to serotypes 1, 2 and 3 with 
planned acceptance of types 4 through 8 in the near future (36). 
The bovine adenoviruses have been divided into two subgroups (4). 
Types 1, 2, 3 and 9 make up the first subgroup with types 4 through 8 in 
the second-subgroup (50). The principal differentiation between the sub­
groups of bovine adenoviruses are: 1) primary isolations of subgroup 1 
can be made on bovine kidney and testicle cell cultures, usually at the 
first passage, whereas subgroup 2 can only be isolated on bovine testicle 
and lung cell cultures after several blind passages; 2) subgroup 1 bovine 
adenoviruses contain the common soluble antigen present also in the human 
strains whereas those of subgroup 2 contain only traces of the common 
soluble antigen of human adenoviruses; and 3) subgroup 1 bovine adenovirus­
es produce a single nuclear inclusion irregular in shape while those of 
subgroup 2 produce multiple inclusions which are circular in shape and 
have a sharp outline (4). Originally it was also thought that subgroup 1 
bovine adenoviruses were heat labile at 56 C for 30 min which would serve 
as a property differentiating between the two subgroups. However, it was 
later reported that adenoviruses lost their heat sensitivity after several 
passages in cell culture and thus heat sensitivity should not be used as a 
criterion in adenoviral classification (10). 
The diseases produced by bovine adenoviruses involve primarily the 
respiratory tract. Adenoviruses have also been reported to infect the eye 
in cattle and humans, and it has been isolated in cases of diarrhea 
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although the exact relationship with gastrointestinal disease is not 
known. The disease is usually self-limiting or inapparent and produces a 
type-specific immunity. 
Areas of consolidation, collapse, and emphysema are the changes ob­
served on gross examination of lungs from infected animals. Regional 
lymph nodes are usually enlarged and pale. Upon microscopic examination 
proliferative bronchiolitis followed by necrosis and bronchiolar occlusion 
are seen. Peribronchiolar and perivascular cuffing by lymphocytes and 
plasma cells is also observed. The intranuclear inclusions in bronchiolar 
epithelium, alveolar cells, and bronchial lymph nodes are considered to be 
of special diagnostic significance in adenovirus infection. 
The first isolations of adenoviruses of bovine origin occurred during 
a search for viruses responsible for the production of poliovirus anti­
bodies in cattle in the United States. Klein and coworkers isolated a 
virus, "Bovine No. 10," in 1956 from the feces of an apparently normal 
adult cow (46). The virus was not characterized and formally described 
until 1959. The virus isolation was made on primary calf kidney cells 
where the original CPE was slight and the titer of the virus remained 
low through several passages. A year later Klein et al. reported on a 
second adenovirus, "Bovine No. 19," which was also isolated as part of 
the saiTic Study (47/. This VITUS woS Tsolatsd Tn primary calf kidney 
cell cultures from the feces of an apparently normal calf. The initial 
virus isolation required long incubation periods (13 days) but later 
CPE, though very mild, occurred in 5 to 6 days. Upon serologic exami­
nation the two isolates proved to be antigenically distinct viruses 
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(45). Human gamma globulin neutralized virus "Bovine No. 19" to a lesser 
extent than virus "Bovine No. 10." The speculation that viruses "Bovine 
No. 10" and "No. 19" represent two as yet unisolated human adenoviruses 
remains unresolved. There is no doubt that these viruses are of bovine 
origin. "Bovine No. 10" and "No. 19" are now known as bovine adenovirus 
serotype 1 (BAV-l) and serotype 2 (BAV-2) respectively. 
Neutralizing substances to BAV-l and BAV-2 are widely distributed in 
the cattle population. When 40 adult cattle in Pennsylvania were tested 
for serum neutralizing antibodies 87% had antibodies to BAV-l and 100% had 
antibodies to BAV-2 (45,45,47). Of 75 sera from Maryland cattle 38% were 
seropositive to BAV-l and 34% to BAV-2 (61). In a survey for the distri­
bution of antibody to BAV-l in Alabama cattle few or no detectable anti­
bodies were observed in young cattle, but cattle 3 years old and older had 
readily detectable antibodies (79). Wizigmann in Germany reported serum 
antibody titers to BAV-l in 79% and to BAV-2 in 85% of the cattle tested 
(93). In a survey in Italy for antibody to BAV-l and BAV-2 in cattle from 
a few days old to 11 years old 68.9% and 77.8%, respectively, were posi­
tive (35). 
The results of experimental infection in calves with BAV-l have been 
varied. The first experimental intranasal inoculation of two susceptible 
animals resulted in no evidence of clinical illness, although both animals 
responded to the virus as indicated by the development of serum antibody 
titers (46). Mohanty and Lillie, using 6 to 12 week old calves, were 
able to produce clinical illness in animals inoculated via the intranasal 
and intratracheal routes but not in those inoculated via the ocular route 
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(62). The animals developed respiratory illness of varying severity 
characterized by coughing, nasal discharge, anorexia, depression, hyper-
pnea, and in several diarrhea. A biphasic febrile response was observed 
in some of the animals. Virus was recovered for 7 days from both respira­
tory tract and rectal swabs from the experimentally infected calves but 
virus was most frequently isolated from rectal swabs. All calves serocon-
verted to the virus. Darbyshire, using strain WBR 50 of BAV-1, which was 
isolated from nasal samples from a calf during a field outbreak of pneu­
monia, reported mild clinical signs and a serologic response in experi­
mentally infected calves (23). By inoculating the prototype strain of 
BAV-1 and of BAV-2 by the respiratory route into colostrum deprived 
calves, Darbyshire and coworkers were able to produce limited clinical 
response (28). Nasal and ocular mucoid and mucopurulent discharges were 
observed. Some animals developed mild diarrhea. One of the calves 
inoculated with BAV-2 died following acute respiratory signs. Virus 
was easily recovered on the first passage in bovine kidney cell cultures 
from calves inoculated with BAV-1 whereas BAV-2 proved to be more diffi­
cult to recover. Attempts at experimental infection by Ide et al., using 
a strain of BAV-1 isolated by Ditchfield, failed to produce clinical signs 
of respiratory or enteric disease (42). Virus was not recovered from ex­
perimentally infected calves although they developed serum antibody titers 
to the virus. 
Additional reported isolates of BAV-1 include the isolation of virus 
from normal calves (63), the isolation cf virus from calves with pneumo-
enteritis (81) and the isolation of virus from calf kidney cell cultures 
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(30). Mohanty and Lillie have reported the isolation of a BAV-2 as an 
adventitious contaminant in primary bovine embryonic kidney cell cultures 
(63). An interesting isolation of an adenovirus in sheep has been re­
ported following a mild outbreak of respiratory disease in lambs (12). 
Isolation of the virus was made on primary and secondary cultures of 
embryonic sheep kidney cells inoculated with nasal discharge from an 
acutely ill animal. The virus was not related to the known ovine adeno­
virus but was related to BAV-2. This isolate produced clinical disease 
in both lambs and calves. 
Bovine adenovirus type 3 (BAV-3) strain WBR 1 was isolated in bovine 
kidney cultures from a swab taken from the eye of an apparently healthy 
cow (25). On the second passage, cellular degeneration was apparent 
after 10 days of incubation. Using this virus Darbyshire and associates 
inoculated colostrum-deprived calves intranasally on the day of birth and 
intratracheally 24 hours later (25). One week post-inoculation the calves 
developed pyrexia and mucoid nasal or conjunctival discharges which lasted 
2 to 4 days. Several calves developed diarrhea during the time of 
pyrexia. One calf died at 3 and another at 6 days post-inoculation. Virus 
was recovered from the feces of the remaining animals for up to 10 days 
and from the eye and nose up to 11 days (one calf after 21 days) post-
inoculation. Inoculation of older calves (5-15 weeks of age) with BAV-3 
strain WBR 1 failed to result in clinical signs of respiratory or enteric 
disease but the virus was isolated from the feces of 2 of 10 calves (42). 
Mattson describes the isolation of a BAV-3 strain 5C from a naturally 
occurring outbreak of pneumoenteritis in a cow-calf herd (51). Clinical 
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signs, which began after 40 to 60% of the cows had calved, included ex­
cessive ocular and nasal discharge, tympanites, colic and diarrhea. Dis­
ease was absent in calves less than one week old with most calves being 
infected at 1 to 4 weeks of age. Early morbidity was low but after about 
2 weeks reached 70-80%. Virus v/as easily recovered from nasal secretions 
of the calves but not from the feces. Passive virus neutralizing anti­
bodies had little effect in affording the calves protection from infec­
tion. Serologic data indicate that the cows converted from a latent to an 
active viral infection thus providing the source of virus for the calves. 
Experimental infection in colostrum-deprived calves via oral, intranasal 
and intratracheal instillation and by aerosol produced a mild clinical re­
sponse similar to that reported for the natural infection (51). Virus was 
recovered from the feces in addition to the conjunctiva, nasal cavity, and 
throat. Changes in the respiratory tract were milder than that reported 
by Darbyshire and co-workers. 
Experimental evidence suggests that BAV-3 is the most virulent of 
types 1, 2 and 3 although all three are involved in natural disease out­
breaks (27). It produces more extensive gross lesions in the respiratory 
tract. Histologically the lung lesions are less discrete and the intra­
nuclear inclusions easier to find. 
Serologic studies of adult slaughter cows in Oregon from 11 herds 
involving 248 samples revealed that 75% of the animals were seropositive 
to BAV-3 (51). Mohanty found 43% of 75 Maryland cattle were positive 
(61). Bibrack and McKercher reported 35.8% of adult cattle and 17.8% of 
the calves they tested were seropositive (13). In a survey for precipi­
tating antibodies to bovine adenovirus in the sera of farm animals and man 
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in Iran, using BAV-3 as antigen, 30.9% of the native cattle and 20% of the 
imported cattle were positive (1). Seropositive animals to all subgroup 1 
bovine adenoviruses should be identified by this test. Wizigmann, in 
Germany, reported antibody to BAV-3 in 52% of the animals examined (93). 
Of 405 serums collected in Italy 84.4% were seropositive (35). 
Over 80 strains of bovine adenovirus have been isolated in Hungary 
from calves which had pneumonia associated with enteritis (2,7). Diarrhea 
was the principal clinical feature of the widespread disease which was 
observed in calves 2 weeks to 4 months old. Losses fluctuated from 5 to 
60% averaging 10%. Susceptible contacts contracted the disease 7 to 10 
days after exposure. Virus was isolated from a variety of tissues which 
included spleen, lung, pharyngeal lymph nodes, kidney, and small intestine 
as well as from bronchial exudates, nasal and conjunctival discharges and 
feces. The isolates produced CPE only after 3-8 blind passages in bovine 
testicle cell cultures and then only in the epithelial cells. Parallel 
cultures in calf kidney epithelial cells produced no cytopathic changes 
after 8-12 blind passages. These adenoviruses differed serologically from 
the prototype strains of BAV-1, 2 and 3 and represent two new serotypes. 
Isolate THT/62 and B4/65 have been designated prototype strains for BAV-4 
and BAV-5, respectively (8). Serotype 4 appears to be the most prevalent 
of these two serotypes. Experimental infection with this virus produced 
clinical syndromes similar to thos3 observed in the natural infection in 
the field and is believed to be the major cause of pneumoenteritis in Hun­
garian calves (3). Tanaka and coworkers in Japan isolated an adenovirus 
from blood specimens from two animals with diarrhea (85,86). This virus 
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was later serotyped as a BAV-4 (54). Experimental infection with this 
isolate resulted in very mild clinical signs. Following intravenous, 
subcutaneous, oral, and intranasal inoculation of one-year-old calves; 
diarrhea was the most frequently observed clinical manifestation of dis­
ease. A very mild fever was recorded in a few of the animals. All the 
animals had viremias of short duration and developed antibody after in­
fection. Two isolates of BAV-4 have been recovered from sick Oregon 
cattle (53). One isolate was from a case of pneumoenteritis in a 1-week-
old bull and the other from an 8-month-old bull with respiratory disease. 
Additional isolations of BAV-4 have been reported from uninoculated 
bovine testicle cell cultures (9,55,69). 
A rise in antibody titer to BAV-4 was observed in 19 (25%) paired 
serum samples from 75 cattle in Japan with diarrheal disease (85). In a 
limited survey of cattle in England with respiratory disease, by Phillip 
and Sands, 21 of 83 (25%) of the sera had antibodies to BAV-4 (69). Of 75 
Maryland cattle 53% had antibodies to BAV-4 and 63% to BAV-5 (61). 
Mattson reported 51% of 246 adult beef and dairy cattle in Oregon had 
serum-viral-neutralizing antibodies to BAV-4 (53). Sixty-two percent of 
the cattle tested by Wizigmann in Germany had BAV-4 antibodies and 41% 
BAV-5 (93).  
In addition to being isolated from calves in Hungary, BAV-5 has 
been reported to have been isolated from newborn calves with polyarthritic 
disease--"weak calf syndrome" (21). It has since that time been deter­
mined that this isolate is a serotype 7 bovine adenovirus and will be 
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discussed with that serotype (M. F. Coria, National Animal Disease Center, 
Ames, Iowa, personal communication). 
The first reported isolation of bovine adenovirus type 6 was made by 
Rondhuis in the Netherlands (76). It was isolated as a latent virus from 
primary calf testicle cell culture. Wilcox in Australia isolated several 
adenoviruses from cattle with conjunctivitis and kerato-conjunctivitis 
(91,92). These viruses fall into two serogroups one of which has been 
identified as BAV-6 (61). Four to eight blind passages in bovine testicle 
cell culture were required before the virus was detected. Experimental 
infection in calves produced a mild catarrhal conjunctivitis with ocular 
discharge and was not typical of that seen in field outbreaks. Cole, in a 
study of calves with pneumonia in Australia, isolated several adenoviruses 
which could be divided into two groups (13). Mohanty identified prototype 
"RG" of one group as being a BAV-6 (61). This virus was the most fre­
quently isolated and was cultured from the lungs and nasal cavity of 
calves with pneumonia and bronchitis. Most produced CPE after 3 passages 
in bovine testicle cell culture. 
Mayer and coworkers isolated an adenovirus from the shoulder lymph 
node of a cow with leukosis (56). While this was closely related to BAV-6 
it was also neutralized by hyperimmune serum against BAV-8 Intravenous 
inoculation of 4- to 13-month-old calves resulted in undulating fever, 
acute rhinitis, swelling of lymph nodes and in some animals mild con­
junctivitis. 
Mohanty, in Maryland, reported 61% of the animals tested for neutral­
izing antibodies to BAV-6 were positive (61). In a study of pneumonic 
13 
calves by Cole, only 11% of the animals tested had antibodies and thus 
BAV-6 did not appear to be the etiologic agent in any of the outbreaks 
which he studied (19). 
Nine strains of adenovirus were isolated from cattle with febrile 
illness in Japan (43). The illness was characterized by fever, watery 
diarrhea, mucous hemorrhagic stools, rhinorrhea, reduced appetite and de­
pression. All strains proved to be the same serotype and unrelated to 
previously reported bovine adenoviruses. Fukuroi strain was chosen as the 
prototype strain for bovine adenovirus type 7 (43,55). This virus was 
originally described as a new type 6. Two BAV-7 have been isolated from 
calves with weak calf syndrome. One was isolated from the buffy coat of 
blood from a calf with weak calf syndrome (strain ID-1) and the other from 
the synovial fluid of a sick calf (strain II-AV) (21,84). Calf testicle 
and calf salivary gland cells were used to isolate ID-1 and bovine 
turbinate cell line was used to isolate II-AV. Experimental infection 
with II-AV resulted in marked pyrexia and occasionally mild diarrhea 
(58). While calves with antibody titers to BAV-7 could be infected, the 
severity of the clinical disease was reduced. Lesions induced in 
colostrum-deprived calves closely resembled lesions seen in naturally 
occurring cases of weak calf syndrome (22). 
Phillip and Sands in England have also reported the isolation of 
serotype 7 from primary bovine testicle cell cultures (69). Seventy-five 
percent of a limited number of sera from cattle following outbreaks of 
respiratory tract disease were positive when tested for antibody titers to 
BAV-7. 
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Serotype 8 of bovine adenovirus was isolated in Hungary from calves 
affected with pneumoenteritis (11). There was a low level of cross reac­
tion between this isolate (Misk/67) and serotypes 4, 5, and 6 of bovine 
adenovirus. In a serosurvey for the incidence of antibody to BAV-8 asso­
ciated with respiratory tract and enteric disease in cattle in Hungary 47 
to 86% (average 73.4%) of the animals had antibodies to BAV-8 (60). 
Guenov and coworkers have reported the isolation of strain "Sofia-
4/67" from tissue cultures of kidney and testis taken from healthy calves 
in Bulgaria (37,38). This virus was originally reported as a BAV-6 and 
later as a new serotype 9 bovine adenovirus. 
Kretzschmar reported the isolation of an adenovirus from calves with 
enzootic pneumonia (48). On cross-neutralization the virus differed from 
BAV-1 through 9. The virus was isolated using bovine testicle cell cul­
tures. This virus can probably be considered to be serotype 10 of bovine 
adenovirus. 
While conducting a study of calf pneumonia Cole in Australia isolated 
an adenovirus, strain BIL, from lung tissue from a 2-month-old calf with 
pneumonia (17,18). Eight passages in bovine testicle cell culture were 
required before obvious CPE developed. Experimental inoculation showed 
little clinical reaction in most calves (20). Dyspnea and a nasal dis­
charge were the only clinical indications of pneumonia. Macroscopic and 
histologic changes were observed at necropsy. Generalized congestion with 
small scattered areas of consolidation on gross observation and a mild 
interstitial pneumonia with mononuclear cell infiltration on microscopic 
observation was noted. These changes observed in the lung were similar 
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to, but considerably milder than, those observed in natural cases. A 
serologic study of pneumonic calves by Cole indicated that 39% of the 
animals had antibodies to strain BIL of bovine adenovirus (19). 
Wilcox in Australia has reported the isolation of an adenovirus, 
strain KC-6,from kerato-conjunctivitis (91,92). The isolation was made on 
bovine testicle cells. 
Mohanty has designated both strain "BIL" and "KC-6" as bovine adeno­
virus type 9 (61). This designation may be the result of an oversight of 
the literature as Guenov and coworkers had already published on their 
isolate as a new serotype 9 of bovine adenovirus. 
These isolates may in fact be BAV-9 but are not the prototype strain. 
The possibility also exists that they could be identical to Kretzschmar's 
isolate (possible serotype 10) or represent a new serotype 11 of bovine 
adenovirus. 
This illustrates some of the confusion in the bovine adenovirus 
literature which results from the increasing numbers of isolations of 
adenovirus and the lack of availability of reference antigens and anti-
sera. 
Immunity and the role of vaccines in the prevention of disease by 
bovine adenovirus is obscure. Evidence suggests that humoral antibody has 
little effect upon the resistance to infection with the bovine adeno­
viruses (20,51,52). There are indications, however, that the severity of 
disease may be modified by the presence of humoral antibodies (58). It 
also appears that the difficulty in isolation of adenoviruses may be 
linked to the production of local or secretory antibody which may be an 
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important factor in overcoming infection or in disease prevention (58). 
Haralambiev and coworkers used high titer hyperimmune serum injected into 
the trachea. This had a prophylactic effect and reduced by 5-fold the 
number of cases of respiratory disease in calves (40). Bovine adenovirus 
vaccination trials have been conducted using both inactivated and modified 
live virus with BAV-1, 3, 4 and 8 used for vaccine trials almost exclu­
sively (3,5,6,14,15,16,70). While vaccinated animals developed titers to 
the vaccine virus the actual degree of protection conferred by the vac­
cines has not been established. 
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MATERIALS AND METHODS 
Cell Cultures 
Two embryonic bovine kidney cell lines were used, namely the Madin-
Darby bovine kidney (MDBK) cell line and the GBK bovine kidney cell line 
developed by R. F. Solarzano, Columbia, Missouri. The GBK cell line con­
tains a mixed cell population. In addition primary and low passage fetal 
calf cells were used. These were embryonic bovine testicle, lung and 
kidney cells. Bovine turbinate (BTu) cells were obtained from M. F. 
Coria, National Animal Disease Center, Ames, Iowa (59). 
The fetal tissues for primary and low passage cells were taken 
aseptically and placed in Dulbecco's modified Eagles minimum essential 
medium (DMEM) with penicillin (100 units), streptomycin (100 pg) and 
amphotericin 3 (20 yg) per ml. The tissues were minced finely with a 
scalpel and the fragments were placed in a 250 ml trypsinizing flask 
containing 100 ml of a 0.25% trypsin solution. The flask was placed on a 
magnetic stirrer for 20 minutes and the cells which were released first 
were discarded. One hundred ml of fresh trypsin were added to the flask 
and the tissue was hydrolyzed for 20 minutes at room temperature. The 
fluid was decanted into two 50 ml conical centrifuge tubes for centrifuga-
tion at low speed (SOD rpm) for 5 minutes. The supernatant fluid then was 
discarded and the cells were suspended in DMEM with antibiotics (10 yg 
amphotericin B) in a volume 10-20 times the packed cell volume. Approxi­
mately 10 ml of the cell suspension were placed in 250 ml (75 cm^) plastic 
tissue culture flasks to which fetal calf serum (FCS) was added to a final 
concentration of 10%. The flasks were incubated at 37C in a 5% carbon 
18 
dioxide (CO2) atmosphere until monolayers were produced at which time the 
medium was changed to DMEM with 2% PCS, or the cells were passaged. The 
medium was removed from cells which were passaged and the cell surface was 
carefully washed with Rinaldine enzyme solution (R-saline), a calcium and 
magnesium free Tyrode's-like solution (75). One to 2 ml of a solution 
containing 0.05% trypsin and 0.01% versene in R-saline (RTV) were added to 
the flask which again was incubated at 37C until the cells detached from 
the flask surface. The cells were harvested in 4 ml of DMEM and dispersed 
by vigorous pipetting 6 to 8 times. The cells were then passed to new 
flasks containing 10 ml of DMEM with antibiotics and 10% PCS. After the 
second passage the antibiotics usually were not needed. The embryonal 
cells could be passaged 8 to 10 times before noticeable slowing of growth 
occurred. 
Cells needed for studies of virus were removed from the flasks as 
described and suspended in DMEM with 2% PCS at a concentration designed to 
give a confluent monolayer within 24 hours. Virus inoculations usually 
were done with the cells in suspension (87). 
Attempts at isolation of virus were made using cells grown in plastic 
tissue culture tubes and plastic tissue culture plates with 24 wells. The 
24-well plates were used for virus titrations and flat-bottom plastic 
tissue culture plates with 35 wells were used for serum-virus neutraliza­
tion tests. 
The cells used in this study were grown and maintained in 250 ml 
(75 cm^) plastic tissue culture flasks or in disposable roller bottles 
(690 cm^). A 0.225% sodium bicarbonate buffer was used in all cell 
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culture media. Antibiotics were used only in initial low passage cell 
preparations and in attempts at isolation of virus from nasal secretion 
material. All cells were propagated at 37C in a 5% CO2 atmosphere. 
All procedures for preparation of tissue culture and inoculation of 
virus were conducted in a positive air flow hood. 
Virus Isolation 
The isolate for this study came from calves in a feedlot operation in 
which the animals were exhibiting signs of acute respiratory tract dis­
ease. The cattle, which originated in North Dakota, were purchased in two 
groups of about 175 animals each through a local auction barn. One group 
had been in the feedlot for 2 weeks, the other for 3 weeks when signs of 
respiratory tract disease were first observed. They had been vaccinated 
for infectious bovine rhinotrachitis (IBR) and given injections of vitamin 
A, D and E upon arrival. The calves had been on feed containing chlor-
tetracycline and sulfamethazine since their arrival. Clinical signs of 
illness included lacrimation, serous rhinitis with accumulations of dried 
exudate on the nose, coughing and inappetence. Temperatures as high as 
41.IC were measured in some of the calves. 
Nasal secretions from 5 calves were taken on sterile cotton swabs and 
placed into tubes containing approximately 2 ml of Eagles minimum essen­
tial medium (MEM), with antibiotics (amphotericin B, 40 ug/ml) and 2% PCS. 
The swabs were expressed and the medium held at 4C for 2 to 4 hours or 
frozen (-70C) until used for attempts at isolation of virus. Serum sam­
ples were drawn from these 6 calves at this time and again 4 weeks later. 
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The calves from which specimens were obtained were given identifying num­
bers FSO-212, FSO-213, FSO-214, FSO-215, FSO-216 and FSO-217 which may 
indicate a nasal secretion sample, serum sample, or virus isolate but will 
always reflect the animal from which the sample was obtained. Virus iso­
late FSO-213 will become synonymous with bovine adenovirus type 3. 
Attempts at isolation of virus were made by inoculating 0.1 ml of 
thawed samples of nasal secretion into 4 tubes containing GBK cells as 
previously described. The initial isolation of FSO-213 was made by M. H. 
Smith at the Veterinary Medical Research Institute. The virus was subse­
quently reisolated from the original sample. The tubes were examined 
daily with an inverted microscope for 10 to 12 days or until cell degener­
ation was observed. When the cultures were beginning to degenerate due to 
age they were passaged until the fifth blind passage was reached. Any 
change in the cell sheet which might suggest the development of a cyto-
pathic effect resulted in further passage of the sample. One to 2 
tenths of a ml of medium, cells and cellular debris was inoculated into 
new tubes or plates when samples were passaged. 
Virus Stocks 
For characterization studies isolate FSO-213 was propagated on MDBK 
cells and plaque purified three times. The medium used for overlays con­
tained lonagar #2 (0.75% final concentration) in basal medium-Eagle (BME) 
supplemented with 2% FCS. Following plaque purification, virus was 
propagated in roller cultures of MDBK cells until maximum CPE was observed 
in the cultures. The cultures were quick frozen in a dry ice-alcohol bath 
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and thawed in a water bath at room temperature. This procedure was re­
peated once and then aliquots of the pool were either frozen (-70C) or 
held in the refrigerator (4C). 
Bovine adenovirus serotype 1, 2 and 3, parainfluenza virus type 3 
(PI-3) SF-4 strain, bovine enterovirus (BE) LCR-4 strain, reovirus type 1 
(Reo 1) and IBR Cooper strain were propagated in stationary cultures of 
MDBK cells and harvested in the manner just described. Bovine viral 
diarrhea virus (BVD) NADL strain was propagated in a similar manner, 
using low-passage BTu cells. These viruses were frozen (-70C) for future 
use. 
Virus Titrations 
Serial 10-fold dilutions of virus were made in DMEM and 0.1 ml 
inoculated into 1 ml cell suspensions of MDBK cells in 24-well plastic 
tissue culture plates. All titrations were performed in quadruplicate. 
The titers for BAV, PI-3. BE. Reo 1 and IBR were determined 7, 2, 2, 2 and 
2 days, respectively, after incubation at 37C in a 5% CO2 atmosphere. The 
BVD titrations were performed in a like manner using BTu cells and the 
results were read at 5 days. The titers were recorded as 50% tissue cul­
ture infective doses (TCID50) calculated by the method of Reed and Muench 
(74). 
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Cytopathogenic Effect and Staining Characteristics 
The CPE in unstained cells was observed in infected monolayers of the 
different cell types prepared as previously described. 
Cells for stained preparations were grown on round coverslips (25 mm) 
or in Leighton tubes. The round coverslips were sterilized by dipping in 
95% ethanol and flaming. They were then placed in plastic tissue culture 
dishes (35 mm x 10 mi). One ml of a cell suspension in DMEM with 2% PCS, 
prepared as previously described, was carefully placed on the coverslip. 
The cells were then infected in suspension using a virus inoculum which 
would produce discrete plaques (100 TCID50/O.I ml). The cells were al­
lowed to attach for 2 to 3 hours before the addition of 2 ml of DMEM 
with 1% PCS which flooded the coverslip washing away unattached cells. At 
predetermined time intervals the coverslips were removed, washed with warm 
R-saline, and placed in the appropriate fixative for the type of staining 
procedure to be used. Methanol fixative was used for May-Grunwald-Giemsa 
(MG-G) and Carnoy's fixative was used for acridine orange staining (71, 
88). Hematoxylin and eosin (H&E) stained preparations were fixed in buf­
fered formalin. Coverslips to be used for immunofluorescence staining 
were air dried, then fixed in cold acetone for 10 minutes. After staining 
and mounting, the cells were examined and photographed with a binocular 
Leitz Orthoplan microscope equipped with a standard light source and a 
fluorescence vertical illuminator and orthomat camera. Standard light 
microscopy was used for MG-G and H&E stained coverslips and ultraviolet 
light for examination of the acridine orange and immunofluorescence 
preparations. Photographs were taken with Panatomic X black and white and 
23 
GAF500 color film. The conjugate for immunofluorescence staining was 
prepared from convalescent sera from experimentally infected calves. 
Virus Characterization 
A 75 cm^ flask of MDBK cells which was infected with FSO-213 was 
harvested by trypsinization for electron microscopy studies when over 75% 
of the cells had CPE due to the virus. The cell culture fluid with cells 
was centrifuged at low speed (800 rpm) to pellet the cells and cellular 
debris. The supernatant was discarded and the pellet was dispersed in a 
minimum volume (1 ml) of distilled water to further lyse cells to release 
the virus. After holding the sample for 1 hour in the refrigerator the 
sample again was centrifuged at low speed and the virus-rich supernatant 
was saved. Two-hundred-mesh grids covered with parlodion and carbon 
coated were used as support for the virus. One drop of the virus prepara­
tion was added to a grid and the excess fluid absorbed with filter paper. 
A drop of 2% potassium phosphotungstate pH 6.8 was then added to the grid 
and removed immediately by drawing off with filter paper. A Hitachi HS-8 
transmission electron microscope was used for scanning the grids. 
The effect of 5-bromo-2'-deoxyuridine (BUdR), an inhibitor of DMA 
synthesis, was tested by an indirect method described by Hamparian et al. 
(39). BUdR at a concentration of 40 ug/ml and BUdR (40 ug/ml) plus 
thymidine (100 ug/ml) was incorporated into the test media. Control 
medium was DMEM with 1% PCS. In addition to the isolate FSO-213, IBR, a 
known DMA virus, and PI-3, a known ribonucleic acid (RNA) virus, were used 
as positive and negative controls, respectively. The cultures were 
harvested when the control flask for each virus exhibited maximum CPE and 
24 
titrated as previously described. A virus was considered to be sensitive 
to the thymidine analog, thus containing DMA, if there was at least a 
100-fold decrease in the virus titer in the flasks which contained BUdR. 
Lipid solvent sensitivity was tested according to the procedure de­
scribed by Feldman and Wang (32). Infectious bovine rhinotracheitis virus 
served as a positive control and BE served as a negative control. Twenty 
volumes of virus suspension were mixed vigorously with one volume of re­
agent grade chloroform for five minutes. The mixture was centrifuged at 
low speed (800 rpm) for 5 minutes and the supernatant fluid was titrated 
as previously described to determine residual infectivity. The virus was 
identified as containing essential lipids if no infectivity was noted. 
The stability to acid pH was tested following the method of Ketler 
et al. (44). One volume of virus suspension was incubated with 10 volumes 
of DMEM adjusted to pH 3.0 for 30 minutes at room temperature. Infectious 
bovine rhinotracheitis virus and BE served as positive and negative con­
trols respectively. Residual infectivity was then titrated as previously 
described. A 100-fold decrease in the titer indicated a sensitivity of 
the virus to low pH. 
Heat sensitivity was tested according to the method of Hamparian 
et al. (39). A tube containing 5 ml of virus was placed in a 56C water 
bath. Aliquots were removed at 0, 5, and 30 minutes. These samples were 
titrated as previously described. Infectious bovine rhinotracheitis virus 
and Reo 1 served as positive and negative controls. A reduction in titer 
was indicative of heat sensitivity. 
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Sera 
Heal thy cattle 
A group of 50 serum samples was obtained from cattle of mixed age, 
sex and breed with no obvious signs of respiratory tract disease. An 
additional 317 serum samples were drawn from cows 2 to 13 years of age 
which were owned by Iowa State University. These animals served as a base 
for establishing the prevalence of BAV-3 in the general cattle population. 
Cattle with respiratory tract disease 
As previously mentioned paired serum samples were taken from the 
calves from which FSO-213 was isolated. In addition paired serum samples 
were available from 152 animals representing 39 herds which experienced 
acute respiratory tract disease. These samples, obtained throughout the 
state of Iowa and representing various breeds and age groups, were col­
lected during the acute phase of respiratory tract disease and a second 
time approximately 4 weeks later. 
High risk cattle 
A third group of cattle from which samples were obtained were normal 
high-risk cattle from an Iowa State University herd which had a history of 
having an outbreak of respiratory tract disease each year within two weeks 
after being moved from one farm to another, a distance of about 40 miles. 
A serum sample was collected on October 18, 1972 a few days after the 
animals had been dehorned, castrated, and separated from their dams but 
two weeks before the anticipated move. The calves did not develop the 
expected signs of respiratory tract disease. A second sample was col­
lected January 12, 1973. On January 25, 1973, an outbreak of acute 
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respiratory tract disease occurred. A final serum sample was taken from 
these calves on March 4, 1973. There was a total of 38 animals for which 
serum samples were available. 
All serum samples were heat inactivated at 56C for 30 minutes. 
Serum-Virus Neutralization Test 
Serum-virus neutralization tests were done in microtiter plates 
using a method similar to the one described by Bibrack and McKercher 
(13). Prior to testing, the serum samples from field cases of bovine 
respiratory tract disease were diluted 4-fold in DMEM. Serum samples from 
experimental calves were used undiluted. Further 2-fold dilutions of the 
test sera were made in microtiter plate wells. All samples were tested in 
quadruplicate. One hundred TCID50 of test virus in a volume equivalent to 
that of the serum (0.05 ml) were added to each well. The serum-virus 
mixtures were incubated for 1 hour at room temperature before the addition 
of 0.05 ml of the appropriate cells at a concentration calculated to allow 
the immediate formation of monolayers. The plates were maintained in a 
CO2 incubator at 37C for the appropriate period for the test virus. The 
serum-virus neutralization titers were considered to be the reciprocal of 
the highest dilution of serum in which 50% of the wells were protected 
1 r UiM uiic virai urc. mi i i i vc i  lcu miurv^uupc wa^  uscu  uv vusc ivc  une vcira. 
A positive and negative sera were included each time a group of sera was 
tested. 
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Serotyping of Isolate FSO-213 
The neutralization index (NI) was used for virus serotype comparison. 
Bovine adenovirus type 1, 2 and 3 were used as test viruses for comparison 
with FSO-213. Fetal calf serum, and pre- and post-inoculation sera from 
the first group of calves experimentally infected with isolate FSO-213 
were used in the NI test as the source for negative and positive serum. A 
sample of isolate FSO-213 was provided to M. F. Coria, National Animal 
Disease Center, Ames, Iowa for confirmation of serotype using antiserum to 
strain 5C of BAV-3 (51). 
Examination for Nonviral Contamination 
The method of Frey et al. was used to culture all cells and viruses 
to determine if mycoplasmal contamination was present (34). Petri plates 
with M-95 medium were streaked with sample material and incubated in a 
microaerophilic environment at 37C for 24 hours. If no colonies were 
present when examined under a microscope, incubation at 37C was carried 
out for an additional 4 to 5 days. 
Chlamydia 
Chlamydia, strain HB24, isolated from dairy calves with respiratory 
tract disease was propagated in 7-day-old embryos inoculated via the yolk 
sac (33). The yolk sacs from embryos which died at day 2 post-inoculation 
or later were harvested, observed for lesions, and washed in phosphate buf­
fered saline to remove excess yolk material. Infectsd yolk sacs for calf 
inoculation were homogenized with a Ten Broeck grinder using approximately 
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2 ml of DMEM per yolk sac. The method described by Reed was used for 
preparation of group specific complement fixing antigen and for the micro-
titer complement fixation test (73). 
Experimental Infectivity Studies in Calves 
Experiment X 
Three calves, designated I-l, 1-2 and 1-3 were used in the first ex­
perimental study of the infectivity of FSO-213. A Hereford calf (I-l) was 
obtained at birth from a herd maintained by the Veterinary Medical Re­
search Institute (VMRI) and two Guernsey calves (1-2 and 1-3) were pur­
chased from a local dairy. The cows were allowed to calve in pasture and 
the calves were removed immediately so that they drank no colostrum. Each 
calf was scrubbed with a 0.01% benzylkonium chloride solution before being 
placed in individual isolation units previously fumigated with formalde­
hyde gas. Serum obtained from a 2-month-old colostrum-deprived calf was 
given orally (100 ml) and subcutaneously (100 ml) to each calf. The 
umbilicus of each calf was dipped in a tincture of iodine solution daily 
until the cord was dry. Powdered nonfat milk was reconstituted with equal 
volumes of sterile 2X Darrows solution and 10% glucose. The calves were 
fed 2 liters of this milk 4 times daily for 10 days. If diarrhea de­
veloped, the powdered milk was omitted and the Darrows-glucosc solution 
was fed for 3 days. Each calf was given 5 ml of a combination of pro­
caine pencillin G (200,000 lU/ml) and dihydrostreptomycin (0.25 g/ml) 
intramuscularly daily for 5 days and at the earliest sign of any enteric 
problem. After 10 days, a commercial milk replacer was gradually 
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substituted for the powdered milk mixture. Commercially formulated feed 
and good quality hay were made available at 1 week. The number of daily 
feedings and amount of milk replacer fed was reduced such that the calves 
were weaned at 2 months. The calves were allowed access to fresh water 
throughout the experiment. 
When the calves were approximately 4 months old, they were inoculated 
intratracheally with 3 ml of tissue culture fluid containing 10^ TCID50 of 
isolate FSO-213 per ml. The calves were observed daily for clinical signs 
of illness. Rectal temperatures were taken and blood samples were col­
lected every other day for 1 week prior to experimental infection and 
daily following inoculation. Blood samples were examined for packed cell 
volume, total leukocyte count, differential leukocyte count, plasma 
fibrinogen, and total serum protein according to standard procedures. 
Serum samples were taken before infection and at 15 and 45 days after 
infection. The pre-inoculation serum sample was tested for antibodies to 
BAV-1, BAV-2, BAV-3 and FSO-213. 
Nasal secretions were obtained on cotton swabs at the time the 
other samples were collected and processed for isolation of virus using 
the same procedures as described earlier. 
Experiment II 
The second experiment involved the use of isolate FSO-213 and a 
chlamydial agent (strain HB24). Two 7-month-old Guernsey calves (II-l and 
II-2) were obtained at the completion of another experiment involving 
bovine respiratory syncytial virus. These calves were raised in isolation 
as previously described. The calves received 5 ml of tissue culture fluid 
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containing 10® TCID50 of FSO-213 per ml intratracheally on day 0. The 
virus was second passage virus which was reisolated from the calves in 
Experiment I. On day 3, one ml of the chlamydial agent (10* embryo lethal 
doseso per ml diluted to 5 ml with serum free DMEM) was inoculated intra-
tracheally. The calves were observed for clinical illness and each ani­
mal's temperature was recorded. Blood and nasal secretion samples were 
collected and processed as previously described. 
Experiment III 
A third experiment utilized two calves (I-l and 1-2) from the first 
experiment. Induction of recrudescence of adenovirus type 3 by treatment 
of the animals with dexamethazone, 20 mg per day for 10 days, 'j at­
tempted. Approximately 5 months had passed from the time of initial in­
fection with FSO-213. Clinical observations were made and rectal tempera­
tures were recorded. Blood and nasal secretion samples were collected and 
processed as previously described. 
Experiment IV 
The fourth experiment involved the use of three Hereford calves from 
the VMRI herd. Two of the calves (IV-1 and IV-2) were allowed to remain 
with the dam until 1 month before they were to be used in the experiment. 
The calves were fed milk replacer and offered a commercially formulated 
feed, good quality hay and water from the first day they were removed from 
their dams. The milk replacer was gradually withdrawn and the calves were 
on full feed by 2 weeks. These calves were inoculated 2 weeks later with 
third passage virus isolated from calves in Experiment I. Five ml of 
virus with a titer of 10® TCID50 per ml were inoculated intratracheally. 
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The third calf {IV-3) was placed in contact with the 2 inoculated calves 
on the second day post-inoculation. This calf was approximately 1 month 
of age. The calf had been on supplemental feeding since birth and was 
removed from the dam at 2 weeks of age. It was on a ration similar to the 
one received by the other calves except that at the time of the experiment 
it was still receiving milk replacer. Nasal secretions and serum samples 
were collected and processed as previously described. Body temperatures 
were recorded and the calves were observed for clinical signs of illness. 
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RESULTS 
Isolation and Culture Characteristics 
Nasal secretion samples FS0-213--FS0-217 obtained from calves with 
acute respiratory tract disease were rapidly thawed at 37C and inoculated 
into GBK, MDBK and BT cells as described. When the cells were beginning 
to degenerate due to age they were subpassaged. At about the fifth blind 
passage of sample FSO-213 on GBK cells granular focal areas developed with 
4 to 8 cells rounding up and becoming refractile. A definite pattern of 
CPE began to emerge at about the tenth passage. With increased passage 
the refractile cells became more numerous and formed foci of degeneration 
or plaques. These cells usually detached and floated in the medium. 
Sample FSO-212, FSO-216 and FSO-217 caused obvious CPE early in the 
first passage on GBK cells. The virus of FSO-212 and FSO-216 was identi­
fied as PI-3 by hemadsorption capability and specific immunofluorescent 
staining and the virus in sample FSO-217 was identified as an IBR virus on 
the basis of specific immunofluorescent staining. The PI-3 and IBR iso­
lates were frozen and efforts were directed toward identification of iso­
late FSO-213. At about the eighth passage the virus was propagated on 
MDBK cells and these cells were used in further work because they produced 
a uniform monolayer. The titer of the virus remained low (10^ TCIDso). 
Virus was purified by selection of plaques and then the titer of the virus 
attainable was increased to 10^ to 10® TCIDso per ml. 
33 
Cytopathology 
Two types of CPE were apparent in MDBK cell monolayers when virus 
titrations were made with isolate FSO-213 (Figure 1). When a high multi­
plicity input (low virus dilution) was used the CPE was complete in about 
3 days. The cells became rounded and cytoplasmic bridges formed. At this 
time, the cells began to detach from the culture flask and the medium be­
came acidic as CPE progressed over the entire monolayer. Low multiplicity 
input (i.e., high virus dilution) resulted in a palisading of cells which 
first became vacuolated and then refractile. The palisading involved 
several hundred cells and developed from a focal area. A "comet-like" 
tail developed from the focal area as time progressed. This ridge of 
cells prevailed until the cell sheet degenerated due to age, about 10 to 
12 days in the case of MDBK cells. If the cell sheet was trypsinized 
prior to degeneration and subpassaged typical CPE would often result. 
May-Grunwald-Giemsa staining was useful in monitoring changes in cells 
as CPE progressed. Madin-Darby bovine kidney cells were grown and infected 
with FSO-213 on round coverslips as described. Coverslips were removed and 
stained at various times post-inoculation. The most prominent intra­
nuclear inclusions were observed in cells early in infection and with 
discrete foci of CPE (Figure 2). Rounded cells with dense staining 
material were evident bordering the plaque. Nuclear pyknosis, karyor-
rhexis and karyolysis developed in many cells. A centrally located 
intranuclear inclusion surrounded by a clear zone was evident in some 
cells. The nuclear membrane was generally thickened in these cells. Some 
Figure 1. Cytopathic effect produced by FSO-213 in MDBK cell line. 
Monolayers, unstained, X80. A. High multiplicity input. 
B. Low multiplicity input. . 
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Figure 2. MDBK cell line infected with FSO-213 after 3 days of 
incubation. May-Grunwald-Giemsa stain, X800. A. Normal 
nucleus. B. Intranuclear inclusion. 
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of the inclusion bodies had filamentous processes which extended to 
the thickened nuclear membrane. 
Hematoxylin-eosin stained preparations revealed many of the same 
changes including the basophilic intranuclear inclusions surrounded by 
clear halos. 
Infected cells stained with acridine orange and viewed under the 
fluorescent microscope contained y^'lowish-green fluorescent material 
which appeared to fill the entire cell. These cells corresponded to the 
dense staining cells observed with MG-G. Intranuclear inclusions were 
observed as yellowish-green fluorescing bodies. 
Immunofluorescent staining of cells early in infection produced 
granular fluorescent particles throughout the nucleus (Figure 3). The 
fluorescence appeared to be greater in intensity near the nuclear mem­
brane. The particles increased in size as the infection progressed with 
time. 
PhysicochciTiical Character; sti cs 
The characteristics of isolate FSO-213 compared with control viruses 
are presented in Table 1. The physicochemical tests indicated the virus 
contained DNA and was chloroform and acid resistant and heat sensitive. 
Sensitivity of FSO-213 to treatment with the thymidine analogue 
BUdR indicated that it contained DNA. 
Since FSO-213 was not sensitive to the lipid solvent chloroform, the 
virus did not contain essential lipid. The rise in titer of FSO-213 and 
the BE used as a control point out the effectiveness of the test. 
Figure 3. MDBK cell line infected with FSO-213 at 36 hours post­
inoculation, immunofluorescent stain, X320. Notice the 
intense nuclear and diffuse cytoplasmic fluorescence. 
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Table 1. Physicochemical characteristics of isolate FSO-213 
Control 
FSO-213 Positive Negative 
Nucleic acid type IBR* PI-3b 
Untreated 4^ 7 6.5 
BUdR^ + thymidine 2 7 6 
BUdR 0.5 4 6 
Lipid solvent IBR BE® 
Untreated 5 7 7.5 
Chloroform 5.5 <1 8 
Acid sensitivity IBR BE 
Untreated 5.5 6.5 7.5 
pH 3.0 5.5 <1 7.5 
Heat sensitivity IBR Reo^ 
Untreated 6 7 5.5 
56C 30 min <1 4 5.0 
^Infectious bovine rhinotracheitis virus, reference strain (Cooper) 
obtained from Veterinary Biologies Division (VBD), USDA, Ames, lA. 
^Parainfluenze-3, reference virus, obtained from VBD, USDA, Ames, lA. 
^Infectious virus titer expressed as log-10 T C I D 5 0  per ml. 
5-bromo-2 ' -deoxyuridi ne. 
^Bovine enterovirus (LCR4) obtained from Veterinary Medical Research 
Institute, Ames, lA. 
^Reovirus type 1 obtained from American Type Culture Collection, 
Rockville, MD. 
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Acid sensitivity tests indicated that isolate FSO-213 was not in­
activated at low pH. It was inactivated, however, by exposure to elevated 
temperature (56C) for 30 minutes. 
Naked (nonenveloped) cubic virus with icosahedral symmetry was ob­
served when preparations of FSO-213 were negatively stained (Figure 4). 
The virions were approximately 80 nm in diameter and contained 252 cap-
somers. The physicochemical and morphologic results suggest isolate 
FSO-213 is an adenovirus. 
Serotyping of Isolate FSO-213 
Pooled convalescent serum from calves (1-2 and 1-3) infected with 
isolate FSO-213 were examined serologically for neutralizing antibody 
using BAV-1, BAV-2 and BAV-3. Bovine adenovirus-1 and BAV-2 were not 
neutralized by the pooled convalescent serum; however, BAV-3 and the 
homologous virus, isolate FSO-213, were neutralized equally well by the 
serum (Table 2). The calves were seronegative to all of these viruses 
prior to inoculation with FSO-213. The serologic results indicate that 
isolate FSO-213 is a bovine adenovirus type 3. This was confirmed by 
M. F. Coria, National Animal Disease Center, Ames, Iowa using antiserum 
prepared in rabbits to strain 5C of BAV-3 provided by D. Mattson, Oregon 
State University, Corvallis, Oregon. 
Serologic Studies 
Healthy cattle 
The results from a study of 50 healthy cattle of mixed ages, sex, 
and breeds tested for serum antibody titer to isolate FSO-213 of BAV-3 are 
Figure 4. Electron micrograph of FSO-213 negatively stained with 
potassium phosphotungstate, pH 6.8. Arrows point out 
penton at apexes of triangles with 6 capsomers per edge. 
Maker = 100 nm. 
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Table 2. Alpha-serum-virus neutralization test for the identification of 
virus isolate FSO-213 
Virus titer 
adenovirus® Strain Negative serum^ FSO-213 antiserum^ NI^ 
Type 1 10 4® 4 0 
Type 2 19 3 3 0 
Type 3 WBRI 4 0 4 
FSO-213 4 0 4 
^Provided by S. B. Mohanty, University of Maryland, College Park, MD. 
'^Pooled pre-inoculation serum from calves 1-2 and 1-3. 
^Pooled post-inoculation serum from calves 1-2 and 1-3. 
^Neutralization index. 
^Infectious titer expressed as logio TCIDso per ml. 
presented in Figure 5a. The titers ranged from less than 4 to 256 with 
the median titer 16. 
The titers of sera from 317 cows 2 years old and older, which were 
owned by Iowa State University, ranged from less than 4 to 256 with a 
median titer of 32 (Figure 5b). 
Cattle with respiratory tract disease 
A total of 157 paired serum samples, representing the investigation 
of 40 outbreaks (herds) of respiratory tract disease, were tested for 
antibody titers to FSO-213. The titers ranged from less than 4 to 256 in 
the acute phase sera and less than 4 to 512 in the convalescent phase 
sera. Both had median titers of 15. Thirty (19.1%) of the calves had a 
4-fold or greater antibody titer rise (seroconversion) between the acute 
Figure 5. Serum antibody titer to bovine adenovirus type 3 in healthy 
cattle. A. Cattle of mixed age, sex and breed. B. Cows 
2 to 13 years old. 
NimtMra of Anknah 
ZZZ3 
Nwrtian of ANmW*  ^
I 
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phase sample and the convalescent phase sample. Of the animals serocon-
verting, the titer rose from a median titer of 4 on acute phase to 32 on 
the convalescent phase. 
Serologic data from 6 (15%) of the herds, including the herd from 
which FSO-213 was isolated, implicate BAV-3 as being involved in the 
respiratory tract disease problem (Tables 3 and 4). There was a 4-fold or 
greater antibody titer rise in serum from 4 of the 5 cattle sampled in the 
herd from which FSO-213 was isolated. The fifth calf had a preexisting 
high titer to BAV-3. 
High-risk cattle 
A first and second bleeding serum sample was available from 38 high-
risk cattle and a third bleeding specimen was available for 32 of the 
animals. A median titer of 8 was observed on the first and third sampling 
and a median titer of 16 on the second serum sample. There was a total 
of 8 seroconversions between the first and second sampling and 2 between 
the second and third, a period when the calves experienced acute respira­
tory tract disease (Table 5). 
Examination for Nonviral Contamination 
Samples of media, cells, and virus were periodically checked for the 
presence of mycoplasma as indicated. No mycoplasma were recovered at any 
time. This is not proof that there was none present but only that none 
could be isolated. The absence of antibiotics in all media except for 
initial isolation provided an efficient monitor for indicating the 
presence of bacterial and fungal contamination. Bacterial and fungal 
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Table 3. Serologic data from 6 herds in which bovine adenovirus type 3 
involvement was implicated in the respiratory tract disease of 
those cattle 
Seroconversion^ Virus(es) 
number BAV-3b IBRC PI-3d BVOe BRSVf Isolated In vaccine 
1 + - - - None None 
2 + + + 4- PI-3 IBR 
3 + - + + PI-3 IBR 
4 + - - - PI-3,IBR,BAV-3 IBR 
5 + - - + PI-3,BRSV None 
6 + + + - + BAV-3 IBR,BVD 
A seroconversion was indicated by at least a 4-fold rise in serum 
antibody titer. Over 50% of the animals tested from a herd had to sero-
convert before the herd was considered positive (+). 
^bovine adenovirus type 3. 
^Infectious bovine rhinotracheitis virus. 
^Parainfluenza type 3 virus. 
"Bovine viral diarrhea virus. 
^Bovine respiratory syncytial virus. 
contamination which rarely was present was usually traced to careless 
laboratory technique. This provided an efficient monitor for indicating 
failures in technique. 
Experimental Infectivity Studies in Calves 
Experiment 
The 3 calves used in the first study were inoculated intratracheally 
with isolate FSO-213 which had been passaged 15 times in MDBK cells. 
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Table 4. Serologic study of calves in the herd from which isolate FSO-213 
was recovered 
Serum antibody titer to isolate FSO-213® 
Calf number Acute phase serum^ Convalescent phase serumC 
FSO-212 8 64 
FSO-213 4 16 
FSO-214 8 64 
FSO-215 ND ND 
FSO-216 8 32 
FSO-217 64 32 
Serum-virus neutralization titer expressed as the reciprocal of the 
highest serum dilution which protected 50% of the wells from the viral 
cytopathic effect. 
'^Drawn from animals at the time of respiratory tract disease out­
break. 
^Drawn from animals approximately 28 days following respiratory tract 
disease outbreak. 
There were no clinical signs of illness until the second day after inocu­
lation at which time 2 of the 3 calves developed a febrile response. The 
third calf developed a febrile response on day 3. A second febrile re­
sponse was noted on day 7 in calves 1-2 and 1-3 (Figure 6). The average 
temperature for the first response was 40C and for the second 40.4C. The 
temperature of the third calf returned to near normal between the two 
temperature peaks while that of the other calf remained slightly elevated 
during this time. All 3 calves were obviously ill. The predominant 
clinical signs were malaise, anorexia, hyperpnea, and dyspnea. These 
clinical signs had their onset with the initial febrile response and 
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Table 5. Serologic investigation of 38 high-risk cattle to determine the 
presence of serum antibody to bovine adenovirus type 3 
Serum-virus neutralization titer* Number 
Sample <4 4 8 16 32 64 128 256 tested versions® 
1 0 8 14^ 7 7 1 1 0 38 0 
2 0 9 8 12^ 5 4 0 0 38 8(21%) 
3 0 9 7^ 10 4 2 0 0 32 2(6%) 
Serum-virus neutralization titer expressed as the reciprocal of the 
highest serum dilution which protected 50% of the wells from the viral 
cytopathic effect. 
seroconversion was indicated by at least a 4-fold rise in serum 
antibody titer. 
^Median titer. 
continued through the second febrile response, although diminishing, and 
could have been overlooked without close observation. All 3 calves had 
hyperemic nasal mucosa. There also appeared to be a slight increase in 
nasal discharge during this period. Calf 1-3 had a mild diarrhea with 
the onset on day 6 post-inoculation with a duration of 2 days. 
Virus was recovered from nasal secretions collected on cotton swabs 
from all 3 calves. Virus was recovered as early as day 2 post-inoculation 
from calf I-l. Four subpassages of this sample were required for re-
isolation of the virus. Virus was isolated from specimens obtained from 
the remaining calves starting on day 3 post-inoculation and continuing 
through day 9 post-inoculation. Initial recovery of the virus was usually 
obtained on first passage in MDBK cells. With the late (day 8 and 9 post-
inoculation) samples, 2 to 3 subpassages were required before viral CPE 
Figure 6. Mean daily temperature and leukocyte count of calves 1-2 
and 1-3 inoculated intratracheal!y with isolate FSO-213 
of bovine adenovirus type 3, leukocyte count, 
temperature. 
Leukocyte Count 
m-
S" o> -
« -
Ibmperature (C) 
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was evident. Attempts at isolation of virus from the diarrheal fecal 
sample were fruitless through the fifth passage. 
The clinical and serologic results of the experimental infectivity 
study are summarized in Table 6. 
Data on the hematologic profile, virus isolation and body temperature 
from the calves are summarized in Table 7. The packed cell volume and 
plasma protein values fell within the normal range. There was a slight 
increase in these values at the time of maximum febrile response. The 
white blood cell count on calf I-l was at a maximum on day 3 post-
inoculation whereas the white blood cell count on the 2 remaining calves, 
which ranged from 10,300 to 4,800, demonstrated a relative leukopenia near 
the time of temperature rise (Figure 6). Fibrinogen values in these 
calves increased at the time of elevated temperature. 
Calf I-l was necropsied on day 5 post-inoculation. One small area 
of atelectasis was found on gross examination in an otherwise normal-
appearing lung. Histologic sections were inconclusive with only scattered 
intranuclear inclusion bodies in the septal cells of the lung. 
Antibody titers to isolate FSO-213 of BAV-3 in the experimental 
calves increased from less than 2 on pre-inoculation sera to 16 and 8 on 
day 15, 128 and 54 on day 45, and 128 for both calves on day 60 post-
inoculation. Serum antibody titers against BVD were less than 2 for calf 
1-3 throughout the experiment and were 2 on pre-inoculation for calf 1-2 
and remained so until day 60 post-inoculation at which time the titer was 
4. 
Table 6. Summary of the results of experimental infectivity study in 3 colostrum-deprived calves 
inoculated intratracheally with isolate FSO-213 of bovine adenovirus type 3 
Serum-virus neutralization titer^ 
FS0-213/BVDb 
Calf 
number 
Maximum 
temperature^ 
Virus 
recovery^ Clinical signs 
Pre-
inoculation 15 days 45 days 60 days 
I-l 39.8/ND® 2-5 hyperpnea 
dyspnea 
anorexia 
<2/2 ND NO ND 
1-2 40.2/40.8 3-9 hyperpnea 
dyspnea 
anorexia 
<2/2 16/2 128/2 128/4 
1-3 40.8/40.1 3-9 hyperpnea 
dyspnea 
anorexia 
diarrhea 
<2/<2 8/<2 64/<2 128/<2 
^Serum-virus neutralization titer expressed as the reciprocal of the highest serum dilution 
which protected 50% of the wells from the viral cytopathic effect. 
'^Bovine viral diarrhea virus. 
^Biphasic febrile response. 
^Days post-inoculation. 
®Not determined, calf I-l was necropsied day 5 post-inoculation. 
Table 7. Hematologic profile, virus recovery, and body temperature from 3 colostrum-deprived calves 
inoculated intratracheally with isolate FSO-213 of bovine adenovirus type 3 
Time rela­
tive to T 
infection Band. Seg. Plasma Fibrino- Virus 1—-
(days) PCV WBC cells cells Lymph. protein gen recovery C 
Calf I-l 
-1 33 7000 70 2450 4200 5.8 300 - 38.7 101.6 
0 29 7500 375 2175 4500 5.7 300 - 39.2 102.6 
+1 28 7100 213 1305 4331 5.7 400 - 39.3 102.8 
+2 32 8000 0 2720 4400 6.0 500 + 39.2 102.5 
+3 ND® 12000 0 6120 4920 6.2 700 + 39.8 103.6 
+4 30 (5200 372 1240 4216 6.0 500 + 39.4 103.0 
+5 29 7100 142 2130 4260 6.2 700 + 39.4 103.0 
Calf 1-2 
-1 32 9000 180 2970 5400 6.3 500 - 38.7 101.6 
0 30 7900 158 2449 4582 6.1 500 - 38.6 101.4 
+1 30 7000 280 2240 3710 6.0 500 - 38.6 101.4 
+2 30 5000 0 1650 2600 6.2 600 - 39.3 102.8 
+3 ND (5300 63 2268 3339 6.5 700 + 40.1 104.2 
+4 30 5800 232 1798 3596 6.4 600 + 40.2 104.4 
+5 29 (5900 69 2484 4071 6.3 500 + 39.3 102.8 
®Not determined. 
Table 7. (Continued) 
Time rela­
tive to 
infection 
(days) PCV WBC 
Band, 
cells 
Seg. 
cells Lymph. 
Plasma 
protein 
Fibrino­
gen 
Virus 
recovery 
Temp. 
C F 
+6 28 4800 ND ND ND 6.0 500 + 39.6 103.3 
+7 25 8800 88 2992 5632 6.3 800 + 40.8 105.4 
+8 27 8400 336 2520 5208 6.5 900 + 39.4 103.0 
+9 25 8300 166 1909 5478 6.3 700 + 39.2 102.6 
+12 25 7700 154 2541 4851 6.1 500 - 39.1 102.4 
+14 24 9300 93 3627 5394 5.8 500 - 38.8 101.8 
+16 27 9500 95 3990 5130 6.0 500 - 38.7 101.6 
Calf I -3 
-1 37 10300 0 3399 6592 5.6 300 - 38.4 101.2 
0 37 9800 196 3332 4018 5.6 400 - 38.7 101.6 
+1 36 6900 138 1932 4209 5.7 400 - 38.3 101.0 
+2 31 5000 50 2100 2600 5.5 400 - 40.8 105.5 
+3 ND 6400 192 2048 4096 5.5 500 +• 39.4 103.0 
+4 30 6000 180 1860 3660 5.5 500 + 38.8 101.8 
+5 30 5600 392 560 4312 5.4 400 + 38.7 101.6 
+6 30 5300 ND ND ND 5.5 500 +/-b 39.4 103.0 
+7 29 8300 83 3652 4399 5.4 600 +/- 40.1 104.2 
^Attempted virus isolation from diarrheal fecal sample. 
Table 7. (Continued) 
Time rela­
tive to 
infection 
(days) PCV WBC 
Band, 
cells 
Seg. 
eel 1 s Lymph. 
Plasma 
protein 
Fibrino­
gen 
Virus 
recovery 
Temp. 
C F 
+8 35 7500 75 2250 4950 6.0 700 + 39.7 103.4 
+9 28 5700 57 1083 4256 5.5 600 + 38.7 101.6 
+12 32 8200 164 2952 4038 5.8 500 - 38.7 101.6 
+14 31 8100 81 2592 4860 5.7 500 - 39.0 102.2 
+16 33 8100 0 3078 4617 5.6 300 - 39.1 102.4 
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Experiment II 
The results obtained from the 2 calves (II-l and II-2) in the second 
experiment were undramatic. These calves were inoculated intratracheally 
with bovine isolate FSO-213 of BAV-3 followed 3 days later with a intra­
tracheal inoculation of HB24, a chlamydial agent. The temperature of the 
calves remained virtually normal through the duration of the experiment. 
Calf II-l had a slight increase in temperature on day 3 post-inoculation. 
While the body temperature of calf I1-2 was elevated on day 3 post-inocu-
lation, it was not significantly above normal. The clinical signs were 
less obvious in these 2 calves when compared with the animals in the first 
experiments. Anorexia, hyperpnea and dyspnea were observed in calf II-l 
and anorexia was the only obvious sign of illness in calf II-2. Both 
calves had a slight cough starting on day 3 and lasting 2 to 3 days. 
Virus was recovered from nasal swabs starting on day 2 post-inocula­
tion in calf II-l and continuing until day 13 post-inoculation. Virus was 
recovered from calf II-2 for a similar period of time. Again, as in the 
first infectivity study, isolation of virus early and late in the infec­
tion required increased passage. The results of this experiment are 
summarized in Table 8. 
Serum titers to isolate FSO-213 were less than 2 for both calves at 
the start of the experiment. The titers were 125 and 256 on day 15 post-
inoculation and 256 and greater than 512 on day 60 post-inoculation. The 
serum titer levels for the chlamydial agent (HB24) were 0 on the pre­
exposure samples and 5 and 40 at day 15 and 10 and 20 at day 60 post-
inoculation. For BVD the antibody titer in serum from calf II-l rose from 
Table 8. Summary of the results of experimental infectivity study in 2 seven-month-old colostrum 
deprived calves inoculated intratracheally with isolate FSO-213 of bovine adenovirus 
type 3 and chlamydia 
Serum titer 
FSO-213*/chlamydia^/BVO* 
Calf 
number 
Maximum 
temperature 
Virus j 
recovery Clinical signs 
Pre-
inoculation 15 days 60 days 
II-l 39.3 2-13 anorexia 
hyperpnea 
dyspnea & 
cough 
<2/0/16 128/5/64 256/10/128 
II-2 39.1 3-11 anorexia & 
cough 
<2/0/2 256/40/2 >512/20/4 
^Serum-virus neutralization titer expressed as the reciprocal of the highest serum dilution 
which protected 50% of the wells from the viral cytopathic effect. 
^Determined by complement fixation test. 
^Bovine viral diarrhea virus. 
^Days post-inoculation. 
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16 on day 0 to 128 at day 60 post-inoculation. The BVD titer for calf 
I1-2 was 4 or less throughout the experiment. 
The hematologic profile, virus recovery, and body temperature from 
the calves are presented in Table 9. 
Experiment III 
Attempts at producing recrudescence of adenovirus type 3 infection in 
2 calves, which were inoculated 5 months previously with isolate FSO-213, 
were unsuccessful. Nasal secretions were passaged 6 times in MDBK cells 
without evidence of viral cytopathic effect. Immunofluorescent tests at 
the first, third and sixth blind passage were also negative. During the 
period of the corticosteroid treatment the calves appeared rough coated 
and had general inappetence. There were no changes in serum antibody 
titers to isolate FSO-213 or to BVD during the experiment. The titers to 
BAV-3 were reduced from those at 60 days post-inoculation (32 on day 150 
and 64 on day 175). The serum-virus neutralization antibody profile for 
isolate FSO-213 for calves 1-2 and 1-3 for 175 days is presented in Table 
10. 
Data on the hematologic profile, virus recovery, and body temperature 
from the calves are presented in Table 11. Of interest was the increase 
in leukocyte count accompanied by lymphocytopenia during treatment. 
Experiment IV 
A fourth experiment was conducted to study the transmissibility of 
isolate FSO-213 in young calves. Two calves were inoculated intra­
tracheal ly with virus isolate FSO-213 and a third calf was placed in 
contact on day 2 post-inoculation. 
Table 9. Hematologic profile, virus recovery, and body temperature from 2 seven-month-old colostrum-
deprived calves inoculated intratracheally with isolate FSO-213 of bovine adenovirus type 
3 and chlamydia 
Time rela­
tive to _ 
infection Band. Seg. Plasma Fibrino- Virus 
(days) PCV VIBC cells cells Lymph. protein gen recovery C 
Calf II-l 
-4 42 8700 ND® ND ND 6.5 300 - 38.6 101.4 
-3 38 8900 89 2136 6052 6.4 200 - 38.9 102.0 
-2 39 9700 0 3492 5820 6.5 300 - 38.6 101.4 
-1 37 9600 0 2304 6336 6.3 300 - 38.6 101.4 
0 39 7900 553 1580 5530 6.3 300 - 38.9 102.1 
+1 35 8300 664 415 7055 6.0 300 - 38.9 102.0 
+2 35 9500 570 2185 6745 6.2 400 + 38.7 101.6 
+3 35 8300 249 1660 6225 6.3 300 + 39.3 102.8 
+4 33 7900 0 1264 6320 6.2 300 + 38.9 102.0 
+5 38 8600 258 1290 6622 6.3 300 + 39.0 102.2 
+6 33 10500 1050 1680 7770 5.8 200 + 39.1 102.4 
+7 31 9300 837 1302 6324 5.7 200 + 39.1 102.4 
+8 34 9300 93 1116 7719 6.4 500 + 39.1 102.4 
+9 36 10300 103 3090 6798 6.1 300 + 39.1 102.4 
+11 36 8800 264 1760 6512 6.3 300 + 38.6 101.4 
^Not determined. 
Table 9. (Continued) 
Time rela-
nfection 
(days) PCV WBC 
Band, 
cells 
Seg. 
cells Lymph. 
Plasma 
protein 
Fibrino­
gen 
Virus 
recovery C F 
+13 36 10300 0 2060 7931 6.3 300 + 38.9 102.0 
+16 35 8800 176 1232 6952 6.3 200 - 39.1 102.4 
Calf II-2 
-4 38 9300 ND ND ND 6.2 300 - 38.4 101.2 
-3 36 8800 0 1936 6248 5.9 200 - 38.6 101.4 
-2 37 8100 0 2106 5589 5.8 200 - 38.9 102.0 
-1 38 9200 736 1932 6072 6.2 200 - 38.9 102.0 
0 36 9900 99 1584 8019 6.2 300 - 38.7 101.6 
+1 35 9200 644 2392 5796 6.3 600 - 38.6 101.4 
+2 33 8400 504 1428 6048 5.7 100 - 38.6 101.4 
+3 32 7600 228 1824 5168 5.8 200 + 39.1 102.4 
+4 34 7500 300 127!) 5775 5.8 300 + 38.9 102.0 
+5 34 8250 495 1980 5610 5.9 300 + 38.7 101.6 
+6 36 9400 1222 2256 5640 5.9 200 + 38.6 101.4 
+7 34 8900 1246 356 7031 6.0 300 + 38.8 101.8 
+8 34 9600 864 1440 6624 6.2 300 + 38.6 101.4 
+9 35 9900 198 1485 7821 6.2 100 + 38.4 101.2 
+11 35 9500 0 2185 7030 6.2 200 + 38.4 101.2 
+13 34 9700 0 1358 8148 6.0 400 - 38.6 101.4 
+16 37 8800 0 2376 6336 6.2 200 - 38.6 101.4 
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Table 10. Serum-virus neutralization titer for bovine adenovirus type 3 
and bovine viral diarrhea virus for a 175 day period in 2 
calves inoculated experimentally with isolate FSO-213 
Serum-virus neutralization titer* 
bav-s'^/bvd^ 
Calf 0 15 da 45 da 60 da 150 da^ 160 da 175 da 
1-2 <2/2 16/2 128/2 128/4 32/4 32/8 64/2 
1-3 <2/<2 8/<2 64/<2 128/<2 32/2 32/<2 64/2 
^Serum-virus neutralization titer expressed as the reciprocal of the 
highest serum dilution which protected 50% of the wells from the viral 
cytopathic effect. 
^Bovine adenovirus type 3. 
^Bovine viral diarrhea virus. 
^Calves treated with dexamethazone, 20 mg per day for 10 days. 
The 2 inoculated calves had a slight increase in body temperature on 
day 3 post-inoculation and, in one of the calves, again on day 8 post-
inoculation. The inoculated calves were anorectic on day 3 post-inocula­
tion and on days 5 through 7. Dyspnea also was observed in the inoculated 
calves on days 5 through 7. These calves had purulent nasal discharges at 
this time. One of the calves had a cough. 
The contact calf developed a febrile response on days 8 and 13 fol­
lowing exposure to the infected animals. On days 10 through 12 this calf 
suffered a mild diarrhea, anorexia, and dyspnea. A slight nasal discharge 
was noted in this calf. 
Virus was recovered from the inoculated calves starting on day 2 
post-inoculation and extending through days 8 and 9. Virus was recovered 
Table 11. Hematologic profile, virus recovery, and body temperature from 2 calves (1-2 and 1-3) 
treated with dexamethazone. The calves had been experimentally infected with isolate 
FSO-213 of bovine adenovirus type 3 five months prior to treatment 
Time rela­
tive to J 
infection Band. Seg. Plasma Fibrino- Virus !_ 
(days) PCV WBC cells cells Lymph. protein gen recovery C 
Calf 1-2 
-10 33 11600 0 2088 9280 6.3 400 38.8 101.8 
-7 32 12200 244 2562 9394 6.2 400 38.8 101.9 
-5 31 11300 113 3277 7571 6.3 400 38.9 102.0 
-3 36 11700 117 2106 9243 6.4 200 38.7 101.6 
0 34 9800 0 1274 8330 6.4 300 38.6 101.5 
+1 31 18600 2604 11346 2604 7.2 600 38.7 101.6 
+2 27 16500 2475 9405 4620 6.8 600 38.3 101.0 
+3 28 14600 1314 8614 4672 6.7 600 38.7 101.6 
+4 28 10800 7020 972 2700 6.7 600 38.8 101.8 
+5 27 9700 2522 4268 2910 6.4 600 38.9 102.1 
+6 ND® NO NO NO NO NO ND 38.9 102.0 
+7 31 10600 1272 6148 2756 6.6 600 38.9 102.0 
+8 30 16400 4756 7544 4100 6.7 700 39.0 102.2 
+9 27 16400 1968 11644 2788 6.5 700 38.9 102.0 
+10 29 16300 3260 10432 2445 6.6 900 38.3 101.0 
*Not determined. 
Table 11. (Continued) 
Time rela­
tive to 
infection 
(days) PCV 
Calf 1-3 
-10 37 6500 0 1430 4940 6.1 400 38.7 101.7 
-7 35 8500 255 1020 6885 6.1 300 38.9 102.0 
-5 41 9500 190 1045 8265 6.5 400 38.8 101.9 
-3 37 8000 480 2400 4960 6.3 100 38.8 101.8 
0 36 8000 160 1280 6480 6.5 300 39.0 102.2 
+1 31 16800 2016 11928 2688 6.6 500 38.9 102.0 
+2 28 16300 1141 11247 3260 6.3 600 39.0 102.2 
+3 32 17700 6372 7080 4248 6.7 600 38.9 102.1 
+4 29 11400 5130 342 5928 6.9 700 38.2 100.8 
+5 27 11000 4400 3850 2640 6.2 500 39.4 103.0 
+6 ND ND ND ND ND ND ND 39.4 103.0 
+7 28 9200 1748 5060 2392 6.1 500 39.4 102.9 
+8 26 14300 3432 5863 5005 6.1 600 39.6 103.2 
+9 26 16000 2800 11680 1440 6.1 600 39.2 102.6 
+10 27 14700 1029 11025 2352 6.2 800 39.2 102.5 
Band. Seg. Plasma Fibrino- Virus —lËHlEi. 
WBC cells cells Lymph. protein gen recovery C 
65 
from the contact calf on day 7 through day 14 post-exposure which corre­
sponded to days 9 through 16 post-inoculation. The initial serum antibody 
titers to isolate FSO-213 for the 2 inoculated calves were 4 and 16 and 
by day 45 post-inoculation the titers were 32 and 64 respectively. The 
contact calf had an original serum titer of less than 2 and at the end of 
the study the titer was 32. Serum antibody titers against BVD were con­
stant during the experiment. 
The clinical and serologic results of Experiment IV are summarized in 
Table 12. Data on the body temperature and virus recovery of the contact 
animal relative to the inoculated calves are presented in Table 13. 
Table 12. Summary of clinical and serological observations on 2 calves (IV-1 and IV-2) infected 
experimentally with isolate FSO-213 of bovine adenovirus type 3 and a contact control 
calf (IV-3) 
Calf 
number 
Maximum 
temperature 
Virus 
recovery Clinical signs 
Serum-
Od 
virus neutralization 
FS0-213/BVD^ 
15 days 
titer® 
45 days 
IV-1 39.7 2-8 anorexia 
dyspnea 
purulent nasal 
discharge 
cough 
4/2 64/2 32/4 
IV-2 39.0 2-9 anorexia 
dyspnea 
purulent nasal 
discharge 
16/4 16/8 64/4 
IV-3 39.1 9-16 anorexia 
dyspnea 
diarrhea 
<2/<2 4/<2 32/<2 
^Serum-virus neutralization titer expressed as the reciprocal of the highest serum dilution 
which protected 50% of the wells from the viral cytopathic effect. 
^Bovine viral diarrhea virus. 
^Relative to days post-inoculation. 
Table 13. Body temperature and virus recovery from 2 calves inoculated with isolate FSO-213 of 
bovine adenovirus type 3 and a contact control calf 
Inoculated calves Contact control 
IV-1 IV-2 IV-3 
Time Virus ^emp. Virus Virus 
(days)® C F recovery C F recovery C F recovery 
-5 38.6 101.4 - 38.7 101.6 - ND^ ND ND 
-2 38.8 101.8 - 38.7 101.6 - ND ND ND 
0 38.7 101.6 - 38.7 101.6 - ND ND ND 
+1 38.8 101.8 - 38.6 101.4 - ND ND ND 
+2 38.9 102.0 + 38.9 102.0 + 38.6 101.4 -
+3 39.7 103.4 + 39.0 102.2 + 38.3 101.0 -
+4 38.6 101.4 + 38.3 101.0 + 38.4 101.2 -
+5 39.0 102.2 + 38.8 101.8 + 38.9 102.0 -
+6 38.6 101.4 + 38.7 101.6 + 38.8 101.8 -
+7 38.2 100.8 + 38.3 101.0 + 38.3 101.0 -
+8 39.6 103.2 + 38.1 100.5 + 38.0 100.4 -
+9 39.0 102.2 - 38.2 100.8 + 38.0 100.4 + 
+10 38.9 102.0 - 38.4 101.2 - 39.1 102.4 + 
+11 38.8 101.8 - 38.8 101.8 - 38.4 101.2 + 
^Relative to the inoculated calves, 
^^ot determined. 
Table 13. (Continued) 
Inoculated calves Contact control 
nm ri^2 ï71 
Time Temp. virus Virus ^emp. Virus 
(days) C F recovery C F recovery C F recovery 
+12 38.6 101.4 - 38.6 101.4 - 38.2 100.8 + 
+13 ND ND ND ND ND ND 39.2 102.5 + 
+14 ND ND ND ND ND ND 38.9 102.0 + 
+15 ND ND ND ND ND ND 38.8 101.8 + 
+16 ND ND ND ND ND ND 38.8 101.8 + 
+17 ND ND ND ND ND ND 38.4 101.2 -
+18 ND ND ND ND ND ND 38.6 101.4 -
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DISCUSSION 
Isolate FSO-213 was obtained as a result of a continued effort to 
isolate, characterize and identify new agents involved in the bovine 
respiratory tract disease complex. 
Several factors may have contributed to the extended incubation 
period before isolation of this virus. The possibility of a low initial 
titer of the virus in the sample must be considered. Secretory IgA, 
interferon or nonspecific inhibitors produced in nasal secretions also 
would make isolation of virus difficult. With subpassage the effects of 
these would be diluted and the possibility of virus isolation would be 
increased. Another contributing factor to the difficulty in virus isola­
tion may be the time (several passages) necessary for the virus to adapt 
to the cell type(s) used for attempts at virus isolation. The attainment 
of a higher titer of isolate FSO-213 following plaque selection may indi­
cate an adaptation of the virus to the cell type (MDBK) but more likely 
was the result of passage at short intervals (90). 
The cytopathic changes that occur in monolayer cell cultures infected 
with isolate FSO-213 are illustrated in the accompanying photographs 
(Figures 1 and 2). Two types of CPE were apparent depending upon the 
multiplicity input. The palisading of cells produced with a low multi­
plicity input is suggestive of cell transformation, a potential of bovine 
adenovirus type 3 as well as many of the other adenoviruses. Although the 
cells have lost their contact inhibition, one of several criteria for cell 
transformation, a lytic infection with the virus occurs following sub-
passage of infected cells. 
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Intranuclear inclusions typical of adenovirus infected cells were 
observed in MG-G-stained preparations. The inclusions were easier to find 
in cells adjacent to plaques where the cells were not as densely stained. 
Similar observations could be made with H&E and acridine orange stained 
preparations as with the MG-G preparation except the results were less 
satisfactory. It was difficult to control the H&E staining process on the 
cells attached to covers!ips to produce the desired contrast. The 
acridine orange stained preparations were not as easy to interpret as the 
MG-G stained preparations since the entire infected cell fluoresced bright 
yellow-green making it difficult to detect intranuclear inclusions. This 
perhaps occurs because the acridine orange preparations are wet mounts 
resulting in rounded infected cells with little observable cytoplasm. The 
intensity of the nuclear staining makes it appear as if there is even less 
cytoplasm. The nuclear fluorescence was characteristic of adenovirus-
infected cells which have been reacted with specific antibody conjugated 
with fluorescein isothiocynate. 
Based on the characteristics presented in Table 1, isolate FSO-213 
belongs to the adenovirus group. Since replication of isolate FSO-213 was 
inhibited in the presence of the thymidine analog BUdR there is little 
doubt that it is a DNA containing virus. 
As clearly indicated by the chloroform test for the presence of 
essential lipid, FSO-213 did not contain essential lipid a fact also 
evident in the electron micrograph (Figure 4). The increase in titer of 
FSO-213 following treatment with chloroform was probably the result of 
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release of virus aggregates by disruption of cell membranes by the lipid 
solvent. It was also obvious that FSO-213 was stable at low pH. 
Heat sensitivity of adenoviruses is a variable characteristic and of 
questionable value in classification. However, isolate FSO-213 was found 
to be definitely heat sensitive. 
As visualized in the electron micrograph (Figure 4), FSO-213 is 
identical in morphology and similar in size to identified adenoviruses. 
Since isolate FSO-213 was obtained after several passages on bovine 
kidney cells it was presumed to be a member of subgroup 1 bovine adeno­
virus. Isolation of bovine adenovirus on bovine kidney cells vs. bovine 
testicle cells, however, is one criterion which is questionable for divi­
sion of the bovine adenoviruses into 2 subgroups. Pooled convalescent 
serum from 2 calves experimentally infected with isolate FSO-213 complete­
ly neutralized the homologous virus as well as BAV-3 strain WBR-1 in an 
alpha-serum-virus neutralization test. There was no cross reaction with 
BAV-1 or BAV-2, a phenomenon occasionally observed when using hyperimmune 
serum in adenovirus serologic analysis. Isolate FSO-213 was also neutral­
ized by antiserum to BAV-3, strain 5C prepared in rabbits providing 
further proof that it is a BAV-3. A 4-fold rise in the titer of serum-
virus neutralizing antibody against the isolate was observed with con­
valescent serum from the animal from which FSO-213 was obtained. Thus the 
virus came from this animal rather than being a latent virus in the cells 
used for virus isolation (Table 4). 
On the basis of serologic studies to determine the prevalence of 
BAV-3 in 50 healthy cattle of mixed ages, sex and breeds, from across 
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Iowa, the virus is widespread in the cattle population. Since these 
cattle are of mixed ages the titers of 8 or less probably represent pas­
sive antibody in younger calves (less than 6 months of age) and the titers 
greater than 8 represent titers of antibody in sera of older animals. 
This cannot be confirmed since the samples were not identified as to the 
age of animals from which they were collected. The median titer of 16 
closely parallels that reported by Bibrack and McKercher in California 
cattle (13). Since serum-virus neutralizing antibody titers to BAV-3 were 
observed in most cows 2 to 13 years of age it may be concluded that nearly 
100% of cows of this age have had experience with BAV-3. The median titer 
for this group is one dilution higher than that of the 50 healthy cattle 
of mixed ages, sex, and breeds and again closely parallels that reported 
by Briback and McKercher. The higher median titer is probably a reflec­
tion of age of the animals in this group. Extreme care must be taken when 
attempting to assess the importance of antibody especially where young 
calves are involved. 
The isolation of BAV-3 from feedlot cattle with acute respiratory 
tract disease has not been reported previously. This demonstrates the 
need to conduct a serologic investigation of feedlot cattle with respira­
tory tract disease to determine the prevalence and extent of involvement 
of this agent. BAV-3 is known to be involved in producing lesions of the 
respiratory tract of younger calves infected either experimentally or 
naturally (23,25,27,42,51,52). The original isolation of BAV-3, strain 
WBRl, was made by Darbyshire and coworkers in Britain from the conjunctiva 
of an apparently healthy cow (25). Mattson isolated a BAV-3, strain 5C 
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from animals in a herd of beef cattle in which he studied naturally 
occurring pneumoenteritis of newborn calves over a period of 4 years (51, 
52). Data from a comparative study of disease response produced by BAV-1, 
2 and 3 indicated that BAV-3 was the most virulent of the three (28). 
Darbyshire and coworkers suggested from serologic evidence that bovine 
adenoviruses were involved in respiratory tract disease of cattle (24,26). 
Of the 157 paired serum samples collected from 40 outbreaks (herds) 
of respiratory tract disease, 19% had a 4-fold or greater BAV-3 antibody 
titer rise between the acute and convalescent phase serum sample. This 
indicates possible involvement of this agent. Since an 8-fold median 
titer rise was observed in the animals which were considered to serocon-
vert it may be concluded that this agent is highly antigenic. As the 
acute median titer was 4, apparently an animal need not be seronegative to 
respond to BAV-3. This observation has been made previously (21,51,52). 
Using the criterion that at least 50% of the animals tested in a herd 
must demonstrate a serologic response to BAV-3 in order for this agent to 
be implicated in the etiology of bovine respiratory tract disease it was 
involved in 15% of the outbreaks by herd (Table 3). The remaining calves 
which seroconverted to the agent are possibly from herds made up of a 
varied immunologic background, i.e., cattle from several sources with 
prior experience to a variety of different agents. Some of the agents 
may or may not be in common resulting in infection by and seroconversion 
to several pathogens. 
Table 3 also contains additional data obtained in conjunction with 
the bovine disease project at the Veterinary Medical Research Institute. 
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Over 50% of the animals tested for the presence of serum antibodies to a 
virus had to seroconvert before the herd was considered positive for that 
virus. Of the 6 herds with seroconversion to BAV-3, herd 1 and 4 are the 
only ones which seroconverted to only BAV-3 of the 5 viruses included. 
Furthermore no virus was isolated from herd 1 indicating that BAV-3 could 
have been the sole virus involved. Both PI-3 and IBR also were isolated 
from herd 4, the herd from which FSO-213 was isolated. The IBR may have 
been from the vaccine. Since PI-3 is a widely distributed virus in the 
cattle population it could be present at a low level in this herd as well 
as in the 2 other herds from which it was isolated in the absence of sero­
conversion (a coincidental isolation). 
The remaining 4 herds present a problem in that they seroconverted to 
more than one agent. It is interesting to note that all 4 seroconverted 
to BRSV a virus recently isolated from cattle with respiratory tract dis­
ease. This virus is gaining increased recognition as a virus of probable 
importance in cattle respiratory tract disease in the United States (49, 
64,72,77,78,83). The other seroconversion noted in these herds are to 
IBR (1 herd which was vaccinated for that virus) PI-3 (2 herds) and BVD 
(2 herds). These viruses have long been recognized as being present as a 
part of the bovine respiratory tract disease complex. 
BAV-3 was isolated from 2 of 6 herds that seroconverted to the virus. 
A BAV-3 was isolated from herd 6 in addition to herd 4. The BAV-3 from 
herd 6 had an adeno-associated virus (AAV) with it which has made working 
with it difficult. Previously only BAV-1 and BAV-2 have been found with 
AAV associated with them (65). 
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Whether or not the disease manifestations observed in these 6 herds 
were due solely or in part to BAV-3 can only be speculation. In 2 of the 
herds (1 and 4) BAV-3 was implicated by serology as the sole viral agent 
responsible for the disease. In the remaining herds (2, 3, 5 and 6) the 
serologic response and isolation of BAV-3 (herd 5) may have been due to 
recrudescence of a latent infection due to stress of concomitant viral 
infections. This is unlikely except in the case of herd 2 where the acute 
titers were high. 
Cattle are capable of undergoing a natural infection as indicated by 
seroconversion in the absence of overt clinical signs of illness. This 
occurred in a herd under Iowa State University management. The respira­
tory illness in these calves shortly after the collection of the second 
serum sample was attributed to BRSV (83). The activity of BAV-3 in these 
calves may have resulted from the decrease in maternal (passive) antibody 
to a point where infection by this virus became possible resulting in a 
serologic response. This would explain the greater number of seroconver­
sions in these calves between the first and second sample collection. 
Experimental inoculation of animals in order to study the patho­
genesis of isolate FSO-213 was not unlike most other attempts to reproduce 
the clinical syndrome observed in naturally occurring outbreaks of bovine 
respiratory tract disease. The failure (if one can call it that) to pro­
duce a fulminating clinical illness in any of the calves was quite pre­
dictable. It is a widely recognized and accepted fact that bovine respi­
ratory tract disease is a complex which includes a variety of clinical 
syndromes. The disease complex is the resulting interaction of stress. 
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and viral and bacterial infection. It is difficult to determine an ex­
perimental challenge dose of an organism equivalent to that contacted by 
animals under field conditions. Attempts at manipulation of stress fac­
tors, and various combinations of bacterial and/or viral agents suspected 
or known to be involved in the bovine respiratory tract disease complex 
have met with variable results. The expectations with FSO-213 were that 
the virus would infect the calves, replicate, and be shed so that it could 
be recovered from nasal secretions. 
Three 4-month-old colostrum-deprived calves were inoculated intra-
tracheally with FSO-213 in approximately the fifteenth passage. The 
clinical signs of illness although mild when compared to natural outbreaks 
of bovine respiratory tract disease were similar to those already reported 
for BAV-3 (23,25,27,51,52). This was a welcome result since any labora­
tory manipulation of a new virus isolate has the potential of altering its 
pathogenic capability. The delay in clinical signs also indicates that 
the response was the result of virus replication rather than adenovirus 
toxin (penton) present in the inoculum. 
Since virus was recovered and serum antibody titer to the virus sub­
sequently developed it can be concluded that the calves had become in­
fected and the clinical signs were attributed to that infection. Recovery 
of virus, which generally lasted for a period of 7 days, was accomplished 
with greater ease in the middle of that period. The difficulty in re­
covery of virus during early infection may be the result of low titer of 
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virus in the nasal secretions. During late infection difficulty in re­
covery of virus may be due to the production of secretory antibody (IgA) 
as well as a decrease in titer of virus. 
The biphasic febrile response observed in the experimental infections 
was assumed to be the result of specific adenovirus activity. This phe­
nomenon has been observed previously with the bovine adenoviruses (56,62). 
Since BVD virus has also been shown to produce a biphasic temperature re­
sponse, the inoculum and MDBK cells were tested using an immunofluorescent 
staining for that virus and found to be negative in each case. This, 
however, does not eliminate the possibility that BVD was present in ex­
tremely low titer or as an antigenic variant undetectable by the particu­
lar immunofluorescent stain used in the test. Serum-virus neutralization 
tests with BVD virus resulted in post-infection titers the same or lower 
than pre-infection titers. Consequently it is unlikely that the biphasic 
febrile response was due to BVD. 
The mild diarrhea which was observed in one of the calves is an 
occasional occurrence in calves experimentally inoculated with adenovirus. 
Attempts at virus isolation from the feces from this calf failed, perhaps 
mainly due to the bacterial and fungal contamination present which de­
stroyed the cell sheet. Treatment of the inoculum with chloroform would 
have been of benefit in controlling this contamination while allowing the 
adenovirus to escape unharmed. 
The hematologic results were analyzed with regard to values presented 
by Schalm et al. and Duncan and Prasse (29,82). The packed cell volume, 
plasma protein and fibrinogen values of the blood samples, while variable 
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were for the most part within normal values for the bovine. The varia­
bility hardly allowed for any conclusions to be drawn. Although the 
leukocyte counts were within the normal range, leukopenia had occurred as 
evidenced in Figure 6. There was also a possible increase in number of 
immature neutrophils in the calves but it was not marked. These are 
classic responses to viral infection. 
One small area of atelectasis was found on gross examination in the 
one calf that was necropsied. The few intranuclear inclusion bodies ob­
served in histologic sections were typical for adenoviral infection. In 
view of the minimal changes observed in tissue from this calf and the 
overall mild clinical response it was felt that killing of additional 
calves for postmortem examination was not justified. 
The results of the second experiment which involved the use of iso­
late FSO-213 and a chlamydial agent were less dramatic than those of the 
first experiment. By using virus which had been passaged back through 
calves and superimposing a chlamydial infection upon the viral infection 
it was hoped that the severity of the clinical response would be in­
creased. The chlamydial agent was one which was isolated from the nasal 
exudate of a calf with respiratory tract disease. 
Tables 8 and 9 contain a summary of the response to the mixed infec­
tion in the 2 calves. 
The febrile response in these calves was all but nonexistent. The 
small temperature rise which was observed occurred during a period similar 
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to that of the first cycle of the biphasic febrile response in the calves 
in the initial experiment. 
Virus was recovered from these calves for a longer period of time 
than in the first experiment, which may indicate persistence of the in­
fection or reflect improved isolation technique. As in the first experi­
ment difficulty in virus isolation was experienced early and late in the 
period of virus recovery. 
A marked antibody response to BAV-3 was observed in the two calves. 
This may indeed indicate the presence of the virus for a longer period of 
time providing for a greater antigenic stimulation. A second possibility 
might be that the concomitant chlamydial infection, which usually produces 
an acute inflammatory response, resulted in an increased immune stimula­
tion for the adenovirus also. Recovery of the chlamydia was not attempted 
but from the serologic response it was presumed that an infection was 
established. 
The BVD antibody titers in these calves was of interest. At the time 
of inoculation calf II-l had a titer of 16 and this was increased 4-fold 
by day 15 post-inoculation which indicates the presence of BVD virus. 
These animals had been used in an experiment involving BRSV and were 
inoculated with that agent approximately 5 months previously. It was 
later shown that the virus inoculum contained a noncytopathic BVD virus 
which was the probable source of stimulation of the original antibody re­
sponse. The increase in antibody following the inoculation of this calf 
with FSO-213 could be an anamnestic response indicating the probable 
presence of BVD virus in this inoculum also. 
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The hematologic results presented in Table 9, while variable, were 
within accepted normal ranges and therefore it is difficult to draw con­
clusions as to their significance. It does appear however that there may 
be a relative leukopenia in the calves with an increase in immature 
neutrophils. 
Recrudescence of adenovirus in the 2 calves previously inoculated 
with FSO-213 was attempted in light of Mattson's work (51,52). He felt 
the calfhood infection which he studied was probably initiated by virus 
shed from the dams, the shedding triggered by stress during the calving 
period. Latent infections with adenovirus result because few infected 
cells are lysed and most of the viral particles remain protected within 
the nuclei of these cells. When these cells are deep in tissue they may 
survive for extended periods of time. 
It was hoped that immunosuppression following corticosteroid treat­
ment would facilitate recrudescence. Cells inoculated with nasal secre­
tions collected from calves following steroid treatment did not exhibit 
CPE nor was any fluorescence observed when inoculated cells were examined 
with specific fluorescent antibody staining. Since there was a lack of 
serum antibody response in these calves recrudescence likely was not 
achieved rather than virus not being isolated. The level of cortico­
steroid administered should have been high enough to produce the desired 
effect. 
Neutralizing antibodies for adenoviruses commonly persist for many 
years with second attacks due to the same virus occurring rarely. Maximum 
titers appear about one month following infection. Heterologous 
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neutralizing antibody rise has been observed following infection with 
adenovirus of a different serotype. On the basis of the serum antibody 
titers for FSO-213 and BVD for a 175 day period, which are presented in 
Table 10, it appears that BAV-3 titer peaks at about 45 to 60 days post­
infection after which it declines to a stable level. 
The BVD titer of calf 1-2 is interesting in that it suggests the 
possible presence of BVD virus. If antibody level is compared from day 0 
to day 150 post-inoculation then a 4-fold antibody titer rise occurred. 
However, if one compares titers from one sample collection to the next 
they continually are within one serum dilution and thus within test error. 
The decrease in BVD titer of calf 1-2 from day 160 to day 175 may be the 
result of the corticoid treatment which inhibits protein synthesis (anti­
body production) although a parallel decrease in BAV-3 titer was not ob­
served. If a followup sample were available at this time it would have 
been interesting to see if the titer level would have returned to or 
above the previous level. 
Corticosteroids produce leukocytosis and lymphocytopenia which 
occurred as is evident in Table 11. The lymphocytolysis is felt to be the 
primary cause of immunosuppression in cattle with corticosteroids. 
The two inoculated calves in the fourth experiment developed mild but 
obvious clinical signs. Experimental results are summarized in Table 12. 
Clinical illness had its onset on day 10 post-inoculation in the contact 
control calf. 
A biphasic febrile response was noted in one inoculated calf and the 
contact control calf. Calf IV-2 had only a slight temperature elevation 
which corresponded in time to that of the first temperature peak of the 
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other calves- This calf also had a preexisting antibody titer to the 
virus which may have had some bearing on the clinical outcome. The pro­
duction of a biphasic febrile response with adenovirus may be age related 
since it was observed only in young calves. 
Virus was recovered for a similar length of time in the inoculated 
calves as in previous experiments. Allowing for appropriate incubation 
period based on virus isolation from experimentally inoculated calves, the 
contact control calf picked up the virus about midperiod of virus shed­
ding. Based on ease of isolation, this is a time when the virus appears 
to be in highest titer in nasal secretions. 
As indicated, calves (IV-2) with preexisting antibody titers to 
adenovirus are capable of being infected. There was, however, in this 
calf a delay in serologic response. The BVD virus antibody titers were 
consistent during the period suggesting BVD virus was not present in the 
inoculum and that the biphasic febrile response was most likely due to 
the BAV-3. 
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SUMMARY 
A search for new viral agents involved in the bovine respiratory 
tract disease complex has resulted in the isolation of a virus (FSO-213) 
from a herd of feedlot cattle with acute respiratory tract disease. 
Physicochemical characterization studies of the virus established 
that it contains DNA, did not contain essential lipid, was stable at low 
pH and was heat labile. Preparations of FSO-213 which were negatively 
stained for electron microscopy revealed naked cubic virus with ico-
sahedral symmetry. The virions were approximately 80 nm in diameter and 
contained 252 capsomers. These characteristics placed the new isolate in 
the adenovirus group. 
Serotyping the virus indicated that it is a serotype 3 of bovine 
adenovirus. The origin of the virus was established by showing an in­
crease in serum antibody titer to the virus in the convalescent serum from 
the animal from which the virus was obtained as well as the seroconversion 
of the other animals in the same herd. 
Serologic studies of healthy animals established the widespread ex­
posure of Iowa cattle to BAV-3. 
Nineteen percent of the animals in a study involving 157 calves rep­
resenting 40 outbreaks (herds) of respiratory tract disease seroconverted 
to BAV-3 indicating possible involvement of this agent. It was implicated 
by serology as being involved in the etiology of respiratory tract disease 
in 6 herds. Bovine adenovirus type 3 was isolated from 2 of these herds 
as well. In one herd it appeared that BAV-3 could have been the sole 
virus involved in the respiratory tract disease based on seroconversion 
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and lack of isolation of other viral agents where as in another herd sero­
conversion to BAV-3 only was observed but BAV-3 as well as other viral 
agents were isolated. The remaining 4 herds present a problem in that 
they seroconverted to more than one agent and other viral agents were 
isolated from them. Whether the disease manifestations observed in these 
6 herds were due solely or in part to BAV-3 can only be speculation. 
Cattle are capable of undergoing a natural infection as indicated by 
seroconversion in the absence of overt clinical signs of illness. It 
appears that maternal (passive) antibody decreases to a point where infec­
tion by this virus becomes possible resulting in a serologic response. 
Experimental infectivity studies in calves were conducted to deter­
mine if isolate FSO-213 was pathogenic. The virus was shown to be capable 
of infecting young (4-months-old) calves. The clinical evidence of ill­
ness, although mild when compared to natural outbreaks of bovine respira­
tory tract disease, was a febrile response, malaise, anorexia, hyperpnea, 
and dyspnea. Hyperemic nasal mucosa with increased nasal discharge was 
also observed. A relative leukopenia near the time of temperature rise 
was observed. Since virus was recovered and serum antibody titer to the 
virus subsequently developed, it was concluded that the calves had become 
infected and the clinical signs were attributed to that infection. 
The clinical response to intercurrent infection with BAV-3 and a 
chlamydial agent were minimal. This may have been due to the age (7-
months-old) of the calves. Virus isolation and subsequent seroconversion 
indicated the calves were infected with isolate FSO-213, Seroconversion 
to the chlamydial agent also indicated that an infection was established. 
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Recrudescence of adenovirus in 2 calves, which were inoculated 5 
months previously with isolate FSO-213 was unsuccessful based on lack of 
virus isolation and lack of serum antibody response in these calves. 
Transmissibility of isolate FSO-213 from 2 inoculated calves to a 
contact control calf was demonstrated. Mild but obvious clinical illness 
developed in these calves. One inoculated calf had a preexisting antibody 
titer to BAV-3 which may have been responsible for the mild clinical re­
sponse observed in this calf. The contact control calf became infected 
about 6 days following exposure to the inoculated calves. Again infec­
tion by FSO-213 was based upon isolation of virus and subsequent sero­
conversion. 
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